H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL INC
Reduce your risk when donating: see where the money actually goes.
Reduce your risk when donating: see where the money actually goes.
Cite this
Plain text H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL INC. furp.org, nonprofit organization profile, tax years 2009–2024. https://furp.org/org/h-lee-moffitt-cancer-center-and-research-institute-hospital-inc-593238634. Retrieved 2026-11-10.
APA furp.org. (n.d.). H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL INC [Nonprofit organization profile; tax years 2009–2024]. Retrieved November 10, 2026, from https://furp.org/org/h-lee-moffitt-cancer-center-and-research-institute-hospital-inc-593238634
MLA “H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL INC.” furp.org, tax years 2009–2024, https://furp.org/org/h-lee-moffitt-cancer-center-and-research-institute-hospital-inc-593238634. Accessed 10 Nov. 2026.
Retrieved 2026-11-10; covers tax years 2009–2024. Data: furp.org (index © the FURP Alliance; the records are public domain).
2024 · Form 990 · revenue $2.64B · expenses $2.19B · assets $517.1M
- Also known as
- RESEARCH INSTITUTE HOSPITAL INC
- EIN
- 59-3238634
- Address
- 12902 MAGNOLIA DRIVE, TAMPA, FL 33612-9416
- Website
- WWW.MOFFITT.ORG
- NTEE code
- E24 Hospital, Specialty (Health Care) published (IRS Business Master File, as E240)
- FURP topic
- science: research education (from its 990 text; the topic index)
- Exempt type
- 501(c)(3): charitable, religious, educational, scientific or literary (corporation)
- Ruling date
- July 1994 (when the IRS recognized its exemption)
- IRS status
- Exempt (unconditional) (IRS Business Master File) IRS data ↗
- Tax-deductible donations
- Yes: listed in IRS Publication 78 (public charity) Pub 78 ↗
- Foundation status
- Hospital or medical research organization
- Cross-check
- ProPublica Nonprofit Explorer
Mission
THE PRIMARY PURPOSE OF THE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. ("HOSPITAL") IS TO CONTRIBUTE TO THE PREVENTION AND CURE OF CANCER.
Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).
People paid by the organization
61 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.
| Name | Latest title | Years | Latest year pay | Total pay from here | Organizations |
|---|---|---|---|---|---|
| G Douglas Letson | FRM EVP-PHYS IN CHIEF TO 6/2024 | 2012-2024 | $1,186,546 | $12,557,547 | 4 |
| Robert Keenan | FRM VP-CHF MED OFFICER TO 1/2024 | 2014-2024 | $291,289 | $7,527,816 | 1 |
| Patrick Hwu | FRM HOSPITAL PRES TO 10/2021 | 2020-2024 | $2,243,616 | $6,784,948 | 4 |
| Yvette M Lyons Tremonti | FRM EVP-CFAO & ASST TREAS TO 5/2024 | 2019-2024 | $596,052 | $6,395,989 | 6 |
| Stuart G Wasserman | CHIEF RAD ONC OFFICER AS OF 7/2024 | 2009-2024 | $477,802 | $6,128,431 | 1 |
| Eduardo G Moros | CHIEF MEDICAL PHYSICS | 2012-2024 | $462,757 | $6,088,135 | 1 |
| L David De La Parte | FRM EVP-GEN CO; ASST SEC TO 6/2024 | 2019-2024 | $1,042,186 | $6,051,346 | 6 |
| Vladimir Feygelman | SR MBR PHYSICIST-RAD ONC | 2009-2024 | $532,522 | $5,893,910 | 1 |
| Joanna Weiss | EVP-CFO & ASST TREAS | 2014-2024 | $972,388 | $5,574,801 | 6 |
| Sarabdeep Singh | HOSPITAL PRESIDENT | 2021-2024 | $1,315,157 | $3,386,273 | 5 |
| Matthew Bednar | VP AMBULATORY/VIRTUAL CARE OPS | 2018-2024 | $584,304 | $3,149,238 | 1 |
| Marilyn Costache | CHIEF RISK OFFICER | 2017-2024 | $324,692 | $1,881,046 | 1 |
| Geoffrey G Zhang | SR MBR PHYSICIST-RAD ONC | 2021-2024 | $487,042 | $1,766,364 | 1 |
| Nicolas Porter | DIRECTOR | 2009-2024 | $0 | $1,750,035 | 5 |
| Henry Reyes | FRM VP-PARTNER DEV TO 4/2024 | 2020-2024 | $130,852 | $1,604,001 | 4 |
| Ken Komorny | VP CHIEF PHARMACY OFFICER | 2019-2024 | $448,015 | $1,601,432 | 2 |
| Terrence Wright | VP FAC & SUP SVCS | 2020-2024 | $486,148 | $1,509,179 | 2 |
| Karen Wartenberg | VP MOFFITT MEDICAL GROUP | 2022-2024 | $626,079 | $1,502,234 | 2 |
| Evan Zaslow | VP PAYER STRATEGIES | 2021-2024 | $554,808 | $1,366,116 | 3 |
| Kelly Gonzalvo | VP PATIENT CARE/CNO | 2022-2024 | $606,645 | $1,332,305 | 1 |
| Tim Hembree | VP CHIEF QUALITY OFFICER | 2023-2024 | $683,723 | $1,292,726 | 1 |
| Wade Sexton | VP CHF MED OFFICER AS OF 7/2024 | 2024 | $988,623 | $988,623 | 1 |
| Christine Alvero | VP HOSPITAL OPS (MMH) | 2023-2024 | $376,163 | $762,601 | 1 |
| Charles Fletcher | EVP-GEN COUN & ASST SEC AS OF 7/2024 | 2024 | $661,814 | $661,814 | 6 |
| Karen Lu | EVP-PHYSICIAN IN CHIEF | 2023-2024 | $634,219 | $634,219 | 3 |
| Melissa Smith | VP FINANCE AS OF 8/2024 | 2024 | $296,400 | $296,400 | 3 |
| John A Kolosky (former) | FRM HOSPITAL PRESIDENT | 2009-2021 | $1,037,996 | $14,256,319 | 5 |
| Alan F List (former) | FORMER EVP-PHYS IN CHIEF | 2009-2017 | $1,787,719 | $11,693,984 | 6 |
| William S Dalton (former) | FORMER PRES/CEO | 2009-2015 | $1,151,569 | $7,567,755 | 5 |
| Jane Fusilero (former) | FRM VP-PAT CARE SVS/CNO TO 2/5/23 | 2010-2023 | $211,501 | $6,053,959 | 1 |
| Louis D De La Parte (former) | EVP-GENERAL COUNSEL;ASST SEC | 2009-2018 | $658,725 | $6,043,348 | 4 |
| Yvette Lyons Tremonti (former) | EVP-CFAO & ASST TREASURER | 2009-2018 | $805,280 | $5,796,352 | 2 |
| W Michael Alberts (former) | FORMER DIRECTOR, VP-MED AFFAIRS | 2009-2019 | $714,931 | $5,546,881 | 2 |
| Braulio Vicente (former) | FRM SVP-MMG HOS OPS TO 11/3/17 | 2009-2018 | $305,179 | $4,625,103 | 2 |
| Julie Djeu (former) | FORMER DIRECTOR, ACD RSCH | 2009-2017 | $521,806 | $3,458,671 | 1 |
| Cynthia Terrano (former) | VP PAYER STRATEGIES TO 3/6/22 | 2015-2021 | $541,575 | $3,367,859 | 2 |
| Bryan Mciver (former) | DEPUTY PHYSICIAN IN CHIEF | 2018-2022 | $576,508 | $3,286,237 | 1 |
| Sachin Apte (former) | ASSOC CHIEF MEDICAL OFFICER | 2016-2020 | $712,921 | $3,048,418 | 1 |
| Janene J Culumber (former) | FORMER SVP-CFO&ASST TREAS | 2009-2015 | $130,196 | $2,795,443 | 4 |
| Mark F Hulse (former) | FORMER HOSPITAL VP-CIO | 2009-2014 | $522,316 | $2,139,153 | 4 |
| W J Wilson (former) | FORMER HOSPITAL VP-GOVT RELATIONS | 2009-2014 | $389,331 | $1,884,346 | 4 |
| Amarjit S Saini (former) | COORD BRACHYTHERAPY PHYSIC | 2012-2017 | $481,656 | $1,821,628 | 1 |
| Thomas Sellers Phd Mph (former) | FORMER EVP-ACD CANCER | 2009-2011 | $668,618 | $1,791,132 | 5 |
| Gene Wetzstein (former) | CHIEF PHARMACY OFFICER THRU 4/2017 | 2010-2016 | $286,306 | $1,749,078 | 1 |
| Siriporn Sarangkasiri (former) | CLINICAL PHYSICIST II | 2009-2015 | $249,491 | $1,669,049 | 1 |
| Brenda S Gordon (former) | FORMER VP-ANCILLARY SVCS | 2009-2014 | $128,349 | $1,516,833 | 1 |
| Scott D Eldredge (former) | FORMER KEY EMP, DEPT ADMIN | 2009-2015 | $224,298 | $1,489,833 | 1 |
| Dean R Head (former) | FORMER HOSPITAL VP-FAC MGMT | 2009-2014 | $174,198 | $1,326,540 | 4 |
| Kenneth M Forster (former) | ASSOC MBR PHYSICIST | 2009-2011 | $294,831 | $894,214 | 1 |
| Brian K Noriega (former) | CLINICAL PHYSICIST II | 2009-2011 | $244,159 | $720,902 | 1 |
| Philip E Johnson (former) | FORMER DIR PHARMACY | 2009-2011 | $212,605 | $660,168 | 1 |
| Marybeth Reardon (former) | FORMER VP-PAT CARE SVS/CNO | 2010-2011 | $288,930 | $587,889 | 1 |
| S Dominic Seraphin (former) | VP STRAT ALLIANCE & NETWK TO 5/15/20 | 2018-2019 | $389,425 | $542,775 | 3 |
| Kenneth Komorny (former) | VP CHIEF PHARMACY OFFICER | 2023 | $398,457 | $398,457 | 2 |
| Mary E Reardon (former) | VP PATIENT CARE SERVICES/C | 2009 | $245,577 | $245,577 | 1 |
| Viet Ho (former) | MANAGER PHARM-CLINIC 5/2017-6/2017 | 2016 | $233,634 | $233,634 | 1 |
| Thomas Henry (former) | CHIEF PHARMACY OFFICER | 2018 | $224,923 | $224,923 | 1 |
| William Franquet (former) | VP REV CYCLE MGMT TO 11/10/14 | 2013-2014 | $213,599 | $213,599 | 2 |
| Kelly Hall (former) | VP/FACULTY AFFAIRS | 2009 | $188,620 | $188,620 | 2 |
| Suresh D Seraphin (former) | FRM VP STRAT ALLIANCE & NETWK | 2020 | $112,463 | $112,463 | 3 |
| Matt Bednar (former) | VP-AMBULATORY OPERATIONS | 2017 | $109,211 | $109,211 | 1 |
Officers and directors, no compensation reported
29 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.
| Name | Latest title | Years | Hrs/wk (latest) | Compensation | Organizations |
|---|---|---|---|---|---|
| Kevin Plummer | DIRECTOR | 2015-2024 | 1 | $0 reported | 8 |
| Joseph Caballero | DIRECTOR, SEC/TREAS | 2009-2024 | 2 | $0 reported | 4 |
| Beth A Houghton | DIRECTOR, PAST CHAIR AS OF 1/2025 | 2009-2024 | 1 | $0 reported | 2 |
| The Hon Mark A Pizzo Esq | DIRECTOR, VICE CHAIR | 2009-2024 | 2 | $0 reported | 2 |
| Hal Walker | DIRECTOR | 2015-2024 | 1 | $0 reported | 1 |
| Jennifer Moffitt | DIRECTOR | 2014-2024 | 1 | $0 reported | 1 |
| Lansing Scriven | DIRECTOR | 2020-2024 | 1 | $0 reported | 2 |
| Mary Anne Reilly | DIRECTOR | 2009-2024 | 1 | $0 reported | 1 |
| Michael Bice | DIRECTOR, CHAIR AS OF 1/2025 | 2013-2024 | 2 | $0 reported | 2 |
| Renee Thompson | DIRECTOR | 2021-2024 | 1 | $0 reported | 1 |
| Robert Horton | DIRECTOR | 2019-2024 | 1 | $0 reported | 1 |
| Roland Daniels | DIRECTOR | 2013-2024 | 1 | $0 reported | 1 |
| Susan Davis | DIRECTOR | 2023-2024 | 1 | $0 reported | 1 |
| The Hon Jacqueline Lewis | DIRECTOR | 2015-2024 | 1 | $0 reported | 1 |
| Valerie Goddard | DIRECTOR | 2011-2024 | 1 | $0 reported | 2 |
| Beth Simonetti (former) | DIRECTOR TO 3/1/24 | 2017-2023 | 1 | $0 reported | 1 |
| Jo Manion (former) | DIRECTOR | 2014-2021 | 1 | $0 reported | 1 |
| Supriya Taneja (former) | DIRECTOR | 2016-2019 | 1 | $0 reported | 1 |
| Bill Horton (former) | DIRECTOR | 2018 | 1 | $0 reported | 1 |
| The Hon H Lee Moffitt Esq (former) | DIRECTOR, SEC/TREAS THRU 9/2016 | 2009-2016 | 1 | $0 reported | 4 |
| Orlando Nieves (former) | DIRECTOR | 2010-2016 | 1 | $0 reported | 2 |
| Charles Paidas (former) | DIRECTOR | 2011-2014 | 1 | $0 reported | 1 |
| Stephen K Klasko Md (former) | DIRECTOR | 2009-2013 | 1 | $0 reported | 1 |
| Dwayne Hawkins (former) | DIRECTOR | 2009-2012 | 1 | $0 reported | 1 |
| Ronald A Hurst (former) | DIRECTOR | 2009-2012 | 1 | $0 reported | 1 |
| Karen Arnold (former) | DIRECTOR | 2009-2011 | 1 | $0 reported | 5 |
| Harvey M Greenberg Md (former) | DIRECTOR | 2009-2011 | 1 | $0 reported | 1 |
| Munya Chiura Phd (former) | DIRECTOR | 2009-2010 | 1 | $0 reported | 1 |
| The Honorable Gwen Miller (former) | DIRECTOR | 2009-2010 | 1 | $0 reported | 1 |
People by year
2024 · 41 people listed · 25 paid, $17.0M · 6,726 employees · 848 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| PATRICK HWU | FRM HOSPITAL PRES TO 10/2021 | 0 | $0 | $1,903,993 | $339,623 | $2,243,616 | 4 |
| SARABDEEP SINGH | HOSPITAL PRESIDENT | 22 | $0 | $1,103,924 | $211,233 | $1,315,157 | 5 |
| G DOUGLAS LETSON | FRM EVP-PHYS IN CHIEF TO 6/2024 | 21 | $426,431 | $597,591 | $162,524 | $1,186,546 | 4 |
| L DAVID DE LA PARTE | FRM EVP-GEN CO; ASST SEC TO 6/2024 | 15 | $0 | $800,163 | $242,023 | $1,042,186 | 6 |
| WADE SEXTON | VP CHF MED OFFICER AS OF 7/2024 | 55 | $434,776 | $390,842 | $163,005 | $988,623 | 1 |
| JOANNA WEISS | EVP-CFO & ASST TREAS | 15 | $0 | $833,387 | $139,001 | $972,388 | 6 |
| TIM HEMBREE | VP CHIEF QUALITY OFFICER | 55 | $563,097 | $0 | $120,626 | $683,723 | 1 |
| CHARLES FLETCHER | EVP-GEN COUN & ASST SEC AS OF 7/2024 | 15 | $0 | $544,342 | $117,472 | $661,814 | 6 |
| KAREN LU | EVP-PHYSICIAN IN CHIEF | 24 | $617,813 | $0 | $16,406 | $634,219 | 3 |
| KAREN WARTENBERG | VP MOFFITT MEDICAL GROUP | 25 | $507,640 | $0 | $118,439 | $626,079 | 2 |
| KELLY GONZALVO | VP PATIENT CARE/CNO | 55 | $506,547 | $0 | $100,098 | $606,645 | 1 |
| YVETTE M LYONS TREMONTI | FRM EVP-CFAO & ASST TREAS TO 5/2024 | 0 | $0 | $530,115 | $65,937 | $596,052 | 6 |
| MATTHEW BEDNAR | VP AMBULATORY/VIRTUAL CARE OPS | 55 | $453,305 | $0 | $130,999 | $584,304 | 1 |
| EVAN ZASLOW | VP PAYER STRATEGIES | 24 | $449,858 | $0 | $104,950 | $554,808 | 3 |
| VLADIMIR FEYGELMAN | SR MBR PHYSICIST-RAD ONC | 50 | $346,780 | $0 | $185,742 | $532,522 | 1 |
| GEOFFREY G ZHANG | SR MBR PHYSICIST-RAD ONC | 50 | $333,766 | $0 | $153,276 | $487,042 | 1 |
| TERRENCE WRIGHT | VP FAC & SUP SVCS | 20 | $0 | $397,226 | $88,922 | $486,148 | 2 |
| STUART G WASSERMAN | CHIEF RAD ONC OFFICER AS OF 7/2024 | 50 | $377,664 | $0 | $100,138 | $477,802 | 1 |
| EDUARDO G MOROS | CHIEF MEDICAL PHYSICS | 50 | $379,567 | $0 | $83,190 | $462,757 | 1 |
| KEN KOMORNY | VP CHIEF PHARMACY OFFICER | 55 | $363,354 | $0 | $84,661 | $448,015 | 2 |
| CHRISTINE ALVERO | VP HOSPITAL OPS (MMH) | 55 | $295,379 | $0 | $80,784 | $376,163 | 1 |
| MARILYN COSTACHE | CHIEF RISK OFFICER | 55 | $267,591 | $0 | $57,101 | $324,692 | 1 |
| MELISSA SMITH | VP FINANCE AS OF 8/2024 | 24 | $0 | $243,695 | $52,705 | $296,400 | 3 |
| ROBERT KEENAN | FRM VP-CHF MED OFFICER TO 1/2024 | 0 | $53,776 | $189,689 | $47,824 | $291,289 | 1 |
| HENRY REYES | FRM VP-PARTNER DEV TO 4/2024 | 0 | $0 | $105,667 | $25,185 | $130,852 | 4 |
| MICHAEL BICE | DIRECTOR, CHAIR AS OF 1/2025 | 2 | $0 | $0 | $0 | $0 | 2 |
| BETH A HOUGHTON | DIRECTOR, PAST CHAIR AS OF 1/2025 | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HON MARK A PIZZO ESQ | DIRECTOR, VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 2 |
| JOSEPH CABALLERO | DIRECTOR, SEC/TREAS | 2 | $0 | $0 | $0 | $0 | 4 |
| ROLAND DANIELS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| SUSAN DAVIS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| VALERIE GODDARD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| ROBERT HORTON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| THE HON JACQUELINE LEWIS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JENNIFER MOFFITT | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| KEVIN PLUMMER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 8 |
| NICOLAS PORTER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 5 |
| MARY ANNE REILLY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| LANSING SCRIVEN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| RENEE THOMPSON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| HAL WALKER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
2023 · 40 people listed · 22 paid, $16.1M · 6,256 employees · 672 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| PATRICK HWU | FRM HOSPITAL PRES AS OF 10/31/21 | 0 | $0 | $1,574,762 | $153,522 | $1,728,284 | 4 |
| YVETTE M LYONS TREMONTI | EVP-CFAO & ASST TREASURER TO 5/17/24 | 12 | $0 | $1,042,682 | $397,146 | $1,439,828 | 6 |
| G DOUGLAS LETSON | EVP-PHYS IN CHIEF TO 6/2/24 | 19 | $1,073,620 | $0 | $302,795 | $1,376,415 | 4 |
| L DAVID DE LA PARTE | EVP-GEN COUNSEL; ASST SEC TO 6/11/24 | 12 | $0 | $865,274 | $392,072 | $1,257,346 | 6 |
| ROBERT KEENAN | VP-CHIEF MEDICAL OFFICER TO 1/20/24 | 55 | $872,224 | $0 | $173,208 | $1,045,432 | 1 |
| SARABDEEP SINGH | HOSPITAL PRESIDENT | 18 | $0 | $872,462 | $120,699 | $993,161 | 5 |
| JOANNA WEISS | EVP-CFAO & ASST TREAS AS OF 5/19/24 | 15 | $0 | $528,314 | $191,655 | $719,969 | 6 |
| KAREN WARTENBERG | VP MOFFITT MEDICAL GROUP | 25 | $442,172 | $0 | $252,329 | $694,501 | 2 |
| VLADIMIR FEYGELMAN | SR MBR PHYSICIST-RAD ONC | 50 | $321,986 | $0 | $321,080 | $643,066 | 1 |
| STUART G WASSERMAN | DIR CLINICAL PHYSICS | 50 | $373,073 | $0 | $268,740 | $641,813 | 1 |
| EDUARDO G MOROS | SR MBR PHYSICIST-RAD ONC | 50 | $379,461 | $0 | $254,349 | $633,810 | 1 |
| GEOFFREY G ZHANG | SR MBR PHYSICIST-RAD ONC | 50 | $317,639 | $0 | $307,680 | $625,319 | 1 |
| TIM HEMBREE | VP CHIEF QUALITY OFF AS OF 7/9/23 | 55 | $252,522 | $212,695 | $143,786 | $609,003 | 1 |
| MATTHEW BEDNAR | VP-AMBULATORY/VIRTUAL CARE OPS | 55 | $404,616 | $0 | $141,408 | $546,024 | 1 |
| KELLY GONZALVO | VP PATIENT CARE/CNO | 55 | $421,985 | $0 | $71,227 | $493,212 | 1 |
| HENRY REYES | VP-PARTNERSHIP DEV TO 4/12/24 | 6 | $0 | $403,439 | $72,651 | $476,090 | 4 |
| EVAN ZASLOW | VP PAYER STRATEGIES | 20 | $389,889 | $0 | $63,653 | $453,542 | 3 |
| TERRENCE WRIGHT | VP-FAC & SUP SVCS | 25 | $0 | $346,707 | $71,550 | $418,257 | 2 |
| KENNETH KOMORNY | VP CHIEF PHARMACY OFFICER | 55 | $308,788 | $0 | $89,669 | $398,457 | 2 |
| CHRISTINE ALVERO | VP, HOSPITAL OPS (MMH) AS OF 7/1/23 | 55 | $250,742 | $0 | $135,696 | $386,438 | 1 |
| MARILYN COSTACHE | CHIEF RISK OFFICER | 55 | $267,751 | $0 | $72,306 | $340,057 | 1 |
| JANE FUSILERO | FRM VP-PAT CARE SVS/CNO TO 2/5/23 | 0 | $182,869 | $0 | $28,632 | $211,501 | 1 |
| BETH A HOUGHTON | DIRECTOR, CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| KAREN LU | EVP-PHYSICIAN IN CHIEF AS OF 6/3/24 | 19 | $0 | $0 | $0 | $0 | 3 |
| THE HON MARK A PIZZO ESQ | DIRECTOR, VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| JOSEPH CABALLERO | DIRECTOR, SEC/TREAS | 1 | $0 | $0 | $0 | $0 | 4 |
| BETH SIMONETTI | DIRECTOR TO 3/1/24 | 1 | $0 | $0 | $0 | $0 | 1 |
| HAL WALKER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JENNIFER MOFFITT | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| KEVIN PLUMMER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 8 |
| LANSING SCRIVEN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| MARY ANNE REILLY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL BICE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| NICOLAS PORTER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 5 |
| RENEE THOMPSON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT HORTON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ROLAND DANIELS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| SUSAN DAVIS | DIRECTOR AS OF 3/1/24 | 1 | $0 | $0 | $0 | $0 | 1 |
| THE HON JACQUELINE LEWIS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| VALERIE GODDARD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
2022 · 36 people listed · 20 paid, $8.3M · 5,471 employees · 570 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| PATRICK HWU | FRM HOSPITAL PRESIDENT TO 10/31/21 | 10 | $0 | $1,161,591 | $102,275 | $1,263,866 | 4 |
| SARABDEEP SINGH | HOSPITAL PRESIDENT | 25 | $0 | $618,920 | $89,732 | $708,652 | 5 |
| ROBERT KEENAN | VP-QUALITY/CMO | 55 | $750,701 | $0 | -$82,673 | $668,028 | 1 |
| G DOUGLAS LETSON | EVP-PHYS IN CHIEF | 15 | $838,552 | $0 | -$245,481 | $593,071 | 4 |
| BRYAN MCIVER | DEPUTY PHYSICIAN IN CHIEF | 50 | $606,810 | $0 | -$30,302 | $576,508 | 1 |
| JANE FUSILERO | VP-PATIENT CARE SVS/CNO TO 2/5/23 | 55 | $496,976 | $0 | $353 | $497,329 | 1 |
| YVETTE M LYONS TREMONTI | EVP-CFAO & ASST TREASURER | 20 | $0 | $824,270 | -$345,650 | $478,620 | 6 |
| HENRY REYES | VP-PARTNERSHIP DEVELOPMENT | 10 | $0 | $340,850 | $45,443 | $386,293 | 4 |
| JOANNA WEISS | SVP FINANCE | 15 | $0 | $448,836 | -$91,001 | $357,835 | 6 |
| EVAN ZASLOW | VP PAYER STRATEGIES AS OF 8/1/22 | 18 | $330,341 | $0 | $27,425 | $357,766 | 3 |
| MATTHEW BEDNAR | VP-AMBULATORY/VIRTUAL CARE OPS | 55 | $341,487 | $0 | $5,574 | $347,061 | 1 |
| L DAVID DE LA PARTE | EVP-GENERAL COUNSEL; ASST SEC | 20 | $0 | $674,699 | -$330,860 | $343,839 | 6 |
| TERRENCE WRIGHT | VP-FAC & SUP SVCS | 25 | $0 | $294,403 | $45,739 | $340,142 | 2 |
| KEN KOMORNY | VP CHIEF PHARM OFF AS OF 9/4/22 | 25 | $271,110 | $0 | $38,704 | $309,814 | 2 |
| EDUARDO G MOROS | SR MBR PHYSICIST-RAD ONC | 50 | $382,910 | $0 | -$119,566 | $263,344 | 1 |
| KELLY GONZALVO | VP PATIENT CARE/CNO AS OF 2/5/23 | 55 | $216,304 | $0 | $16,144 | $232,448 | 1 |
| MARILYN COSTACHE | CHIEF RISK OFFICER | 55 | $78,014 | $111,530 | $16,565 | $206,109 | 1 |
| KAREN WARTENBERG | VP MOFFITT MEDICAL GROUP | 30 | $369,715 | $0 | -$188,061 | $181,654 | 2 |
| STUART G WASSERMAN | DIR CLINICAL PHYSICS | 50 | $303,237 | $0 | -$163,795 | $139,442 | 1 |
| GEOFFREY G ZHANG | SR MBR PHYSICIST-RAD ONC | 50 | $307,110 | $0 | -$220,485 | $86,625 | 1 |
| BETH A HOUGHTON | DIRECTOR, CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HON MARK A PIZZO ESQ | DIRECTOR, VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| JOSEPH CABALLERO | DIRECTOR, SEC/TREAS | 1 | $0 | $0 | $0 | $0 | 4 |
| BETH SIMONETTI | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| HAL WALKER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JACQUELINE LEWIS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JENNIFER MOFFITT | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| KEVIN PLUMMER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 8 |
| LANSING SCRIVEN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| MARY ANNE REILLY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL BICE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| NICOLAS PORTER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 5 |
| RENEE THOMPSON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT HORTON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ROLAND DANIELS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| VALERIE GODDARD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
2021 · 38 people listed · 20 paid, $13.5M · 5,198 employees · 629 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| PATRICK HWU | HOSPITAL PRESIDENT TO 10/31/21 | 10 | $0 | $1,308,625 | $21,259 | $1,329,884 | 4 |
| YVETTE M LYONS TREMONTI | EVP-CFAO & ASST TREASURER | 20 | $0 | $986,249 | $198,291 | $1,184,540 | 6 |
| G DOUGLAS LETSON | EVP-PHYS IN CHIEF | 15 | $975,782 | $0 | $177,397 | $1,153,179 | 4 |
| L DAVID DE LA PARTE | EVP-GEN COUNSEL & ASST SEC | 20 | $0 | $828,758 | $245,597 | $1,074,355 | 6 |
| JOHN A KOLOSKY | FRM HOSPITAL PRESIDENT | 0 | $0 | $729,922 | $308,074 | $1,037,996 | 5 |
| ROBERT KEENAN | VP-QUALITY/CMO | 55 | $808,557 | $0 | $101,150 | $909,707 | 1 |
| BRYAN MCIVER | DEPUTY PHYSICIAN IN CHIEF | 50 | $625,492 | $0 | $95,679 | $721,171 | 1 |
| JANE FUSILERO | VP-PATIENT CARE SVS/CNO | 55 | $585,571 | $0 | $56,342 | $641,913 | 1 |
| JOANNA WEISS | SVP FINANCE AS OF 3/6/22 | 15 | $0 | $460,336 | $144,960 | $605,296 | 6 |
| EDUARDO G MOROS | SR MBR PHYSICIST-RAD ONC | 50 | $413,120 | $0 | $186,654 | $599,774 | 1 |
| GEOFFREY G ZHANG | SR MBR PHYSICIST-RAD ONC | 50 | $319,893 | $0 | $247,485 | $567,378 | 1 |
| VLADIMIR FEYGELMAN | SR MBR PHYSICIST-RAD ONC | 50 | $321,819 | $0 | $237,818 | $559,637 | 1 |
| STUART G WASSERMAN | DIR CLINICAL PHYSICS | 50 | $321,202 | $0 | $237,695 | $558,897 | 1 |
| CYNTHIA TERRANO | VP PAYER STRATEGIES TO 3/6/22 | 35 | $421,106 | $0 | $120,469 | $541,575 | 2 |
| MATTHEW BEDNAR | VP-AMBULATORY/VIRTUAL CARE OPS | 55 | $350,508 | $0 | $122,182 | $472,690 | 1 |
| HENRY REYES | VP-PARTNERSHIP DEVELOPMENT | 17 | $0 | $362,579 | $40,416 | $402,995 | 4 |
| SARABDEEP SINGH | HOSPITAL PRESIDENT AS OF 11/1/21 | 25 | $0 | $355,141 | $14,162 | $369,303 | 5 |
| KEN KOMORNY | CHIEF PHARMACY OFFICER | 55 | $245,682 | $0 | $58,380 | $304,062 | 2 |
| TERRENCE WRIGHT | VP-FAC & SUP SVCS | 25 | $0 | $250,805 | $13,827 | $264,632 | 2 |
| MARILYN COSTACHE | CHIEF RISK OFFICER | 55 | $0 | $188,436 | $53,374 | $241,810 | 1 |
| BETH A HOUGHTON | DIRECTOR, CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HON MARK A PIZZO ESQ | DIRECTOR, VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| JOSEPH CABALLERO | DIRECTOR, SEC/TREAS | 1 | $0 | $0 | $0 | $0 | 4 |
| BETH SIMONETTI | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| HAL WALKER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JACQUELINE LEWIS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JENNIFER MOFFITT | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JO MANION | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| KEVIN PLUMMER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 8 |
| LANSING SCRIVEN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| MARY ANNE REILLY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL BICE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| NICOLAS PORTER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 5 |
| RENEE THOMPSON | DIRECTOR AS OF 11/1/21 | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT HORTON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ROLAND DANIELS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| VALERIE GODDARD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| EVAN ZASLOW | VP PAYER STRATEGIES AS OF 3/7/22 | 55 | $0 | $0 | $0 | $0 | 3 |
2020 · 36 people listed · 19 paid, $13.4M · 4,762 employees · 465 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| JOHN A KOLOSKY | HOSPITAL PRESIDENT TO 1/4/2021 | 23 | $0 | $1,028,625 | $760,536 | $1,789,161 | 5 |
| YVETTE M LYONS TREMONTI | EVP-CFAO & ASST TREASURER | 20 | $0 | $1,047,333 | $362,800 | $1,410,133 | 6 |
| G DOUGLAS LETSON | EVP-PHYS IN CHIEF | 15 | $1,011,339 | $0 | $199,081 | $1,210,420 | 4 |
| L DAVID DE LA PARTE | EVP-GENERAL COUNSEL; ASST SEC | 20 | $0 | $927,786 | $282,255 | $1,210,041 | 6 |
| ROBERT KEENAN | VP-QUALITY/CMO | 55 | $976,677 | $0 | $96,197 | $1,072,874 | 1 |
| SACHIN APTE | ASSOC CHIEF MEDICAL OFFICER | 50 | $610,681 | $0 | $102,240 | $712,921 | 1 |
| BRYAN MCIVER | DEPUTY PHYSICIAN IN CHIEF | 50 | $606,354 | $0 | $102,411 | $708,765 | 1 |
| VLADIMIR FEYGELMAN | SR MBR PHYSICIST-RAD ONC | 50 | $318,888 | $0 | $381,441 | $700,329 | 1 |
| JANE FUSILERO | VP-PATIENT CARE SVS/CNO | 55 | $613,629 | $0 | $60,516 | $674,145 | 1 |
| JOANNA WEISS | VP FINANCE | 15 | $0 | $487,230 | $137,334 | $624,564 | 6 |
| EDUARDO G MOROS | SR MBR PHYSICIST-RAD ONC | 50 | $421,766 | $0 | $178,024 | $599,790 | 1 |
| CYNTHIA TERRANO | VP PAYER STRATEGIES | 35 | $468,352 | $0 | $85,293 | $553,645 | 2 |
| STUART G WASSERMAN | DIR CLINICAL PHYSICS | 50 | $344,238 | $0 | $205,960 | $550,198 | 1 |
| MATTHEW BEDNAR | VP-AMBULATORY/VIRTUAL CARE OPS | 55 | $375,693 | $0 | $91,812 | $467,505 | 1 |
| KEN KOMORNY | CHIEF PHARMACY OFFICER | 55 | $235,003 | $0 | $57,210 | $292,213 | 2 |
| MARILYN COSTACHE | CHIEF RISK OFFICER | 1 | $0 | $192,175 | $55,741 | $247,916 | 1 |
| PATRICK HWU | HOSPITAL PRESIDENT AS OF 1/4/2021 | 25 | $0 | $219,210 | $88 | $219,298 | 4 |
| HENRY REYES | VP-PARTNERSHIP DEVELOPMENT | 12 | $0 | $195,717 | $12,054 | $207,771 | 4 |
| SURESH D SERAPHIN | FRM VP STRAT ALLIANCE & NETWK | 0 | $0 | $112,221 | $242 | $112,463 | 3 |
| BETH A HOUGHTON | DIRECTOR, CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HON MARK A PIZZO ESQ | DIRECTOR, VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| JOSEPH CABALLERO | DIRECTOR, SEC/TREAS | 1 | $0 | $0 | $0 | $0 | 4 |
| BETH SIMONETTI | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| HAL WALKER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JACQUELINE LEWIS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JENNIFER MOFFITT | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JO MANION | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| KEVIN PLUMMER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 8 |
| LANSING SCRIVEN | DIRECTOR AS OF 11/2020 | 1 | $0 | $0 | $0 | $0 | 2 |
| MARY ANNE REILLY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL BICE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| NICOLAS PORTER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 5 |
| ROBERT HORTON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ROLAND DANIELS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| VALERIE GODDARD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| TERRENCE WRIGHT | VP-FAC & SUP SVCS AS OF 3/29/2021 | 20 | $0 | $0 | $0 | $0 | 2 |
2019 · 34 people listed · 18 paid, $13.2M · 4,488 employees · 803 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| JOHN A KOLOSKY | HOSPITAL PRESIDENT | 23 | $0 | $998,205 | $960,228 | $1,958,433 | 5 |
| YVETTE M LYONS TREMONTI | EVP-CFAO & ASST TREASURER | 20 | $0 | $964,941 | $321,875 | $1,286,816 | 6 |
| G DOUGLAS LETSON | EVP-PHYS IN CHIEF | 15 | $960,289 | $0 | $256,848 | $1,217,137 | 4 |
| L DAVID DE LA PARTE | EVP-GENERAL COUNSEL;ASST SEC | 20 | $0 | $794,823 | $328,756 | $1,123,579 | 6 |
| ROBERT KEENAN | VP-QUALITY/CMO | 55 | $756,041 | $0 | $138,931 | $894,972 | 1 |
| W MICHAEL ALBERTS | FORMER DIRECTOR, VP-MED AFFAIRS | 0 | $0 | $339,064 | $375,867 | $714,931 | 2 |
| SACHIN APTE | ASSOC CHIEF MEDICAL OFFICER | 50 | $594,564 | $0 | $97,596 | $692,160 | 1 |
| BRYAN MCIVER | DEPUTY PHYSICIAN IN CHIEF | 50 | $594,669 | $0 | $97,379 | $692,048 | 1 |
| JANE FUSILERO | VP-PATIENT CARE SVS/CNO | 55 | $550,151 | $0 | $55,467 | $605,618 | 1 |
| STUART G WASSERMAN | DIR CLINICAL PHYSICS | 50 | $335,032 | $0 | $234,632 | $569,664 | 1 |
| EDUARDO G MOROS | SR MBR PHYSICIST-RAD ONC | 50 | $377,511 | $0 | $188,842 | $566,353 | 1 |
| VLADIMIR FEYGELMAN | SR MBR PHYSICIST-RAD ONC | 50 | $268,350 | $0 | $291,698 | $560,048 | 1 |
| JOANNA WEISS | VP FINANCE | 15 | $0 | $418,125 | $138,073 | $556,198 | 6 |
| CYNTHIA TERRANO | VP PAYER STRATEGIES | 35 | $448,738 | $0 | $81,135 | $529,873 | 2 |
| MATTHEW BEDNAR | VP-AMBULATORY OPS/VIRTUAL CARE | 55 | $328,642 | $0 | $80,716 | $409,358 | 1 |
| S DOMINIC SERAPHIN | VP STRAT ALLIANCE & NETWK TO 5/15/20 | 15 | $0 | $338,688 | $50,737 | $389,425 | 3 |
| KEN KOMORNY | CHIEF PHARMACY OFFICER | 55 | $219,782 | $0 | $27,546 | $247,328 | 2 |
| MARILYN COSTACHE | CHIEF RISK OFFICER | 1 | $0 | $187,528 | $46,554 | $234,082 | 1 |
| BETH A HOUGHTON | DIRECTOR, CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HON MARK A PIZZO ESQ | DIRECTOR, VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| JOSEPH CABALLERO | DIRECTOR, SEC/TREAS | 1 | $0 | $0 | $0 | $0 | 4 |
| MICHAEL BICE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| ROLAND DANIELS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| VALERIE GODDARD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| ROBERT HORTON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JACQUELINE LEWIS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JO MANION | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JENNIFER MOFFITT | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| KEVIN PLUMMER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 8 |
| NICOLAS PORTER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 5 |
| MARY ANNE REILLY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| BETH SIMONETTI | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| SUPRIYA TANEJA | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| HAL WALKER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
2018 · 35 people listed · 19 paid, $9.2M · 4,199 employees · 882 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| G DOUGLAS LETSON | EVP-PHYS IN CHIEF | 15 | $872,364 | $0 | -$8,011 | $864,353 | 4 |
| JOHN A KOLOSKY | HOSPITAL PRESIDENT | 23 | $0 | $909,324 | -$64,053 | $845,271 | 5 |
| YVETTE LYONS TREMONTI | EVP-CFAO & ASST TREASURER | 20 | $0 | $807,960 | -$2,680 | $805,280 | 2 |
| ROBERT KEENAN | VP-QUALITY/CMO | 55 | $677,182 | $0 | $41,227 | $718,409 | 1 |
| LOUIS D DE LA PARTE | EVP-GENERAL COUNSEL;ASST SEC | 20 | $0 | $685,964 | -$27,239 | $658,725 | 4 |
| SACHIN APTE | ASSOC CHIEF MEDICAL OFFICER | 50 | $597,142 | $0 | $49,932 | $647,074 | 1 |
| BRYAN MCIVER | DEPUTY PHYSICIAN IN CHIEF | 50 | $556,920 | $0 | $30,825 | $587,745 | 1 |
| JANE FUSILERO | VP-PATIENT CARE SVS/CNO | 55 | $500,842 | $0 | $38,196 | $539,038 | 1 |
| CYNTHIA TERRANO | VP PAYER STRATEGIES | 35 | $412,789 | $0 | $66,112 | $478,901 | 2 |
| EDUARDO G MOROS | SR MBR PHYSICIST-RAD ONC | 50 | $388,799 | $0 | $22,978 | $411,777 | 1 |
| W MICHAEL ALBERTS | FRM DIRECTOR, MED DIR MCK | 0 | $0 | $387,872 | $3,257 | $391,129 | 2 |
| JOANNA WEISS | VP FINANCE | 15 | $0 | $360,898 | $23,359 | $384,257 | 6 |
| MATTHEW BEDNAR | VP-AMBULATORY OPS/VIRTUAL CARE | 55 | $283,941 | $0 | $38,355 | $322,296 | 1 |
| STUART G WASSERMAN | DIR CLINICAL PHYSICS | 50 | $319,951 | $0 | -$5,091 | $314,860 | 1 |
| VLADIMIR FEYGELMAN | SR MBR PHYSICIST-RAD ONC | 50 | $300,975 | $0 | $6,296 | $307,271 | 1 |
| BRAULIO VICENTE | FRM SVP-MMG HOS OPS TO 11/3/17 | 0 | $331,359 | $0 | -$26,180 | $305,179 | 2 |
| THOMAS HENRY | CHIEF PHARMACY OFFICER | 55 | $213,097 | $0 | $11,826 | $224,923 | 1 |
| MARILYN COSTACHE | CHIEF RISK OFFICER | 55 | $0 | $171,312 | $32,545 | $203,857 | 1 |
| S DOMINIC SERAPHIN | VP STRATEGIC ALLIANCE & NETWK | 15 | $0 | $154,055 | -$705 | $153,350 | 3 |
| BETH A HOUGHTON | DIRECTOR, CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HON MARK A PIZZO ESQ | DIRECTOR, VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| JOSEPH CABALLERO | DIRECTOR, SEC/TREAS | 1 | $0 | $0 | $0 | $0 | 4 |
| MICHAEL BICE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| ROLAND DANIELS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| VALERIE GODDARD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| BILL HORTON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JACQUELINE LEWIS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JO MANION | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JENNIFER MOFFITT | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| KEVIN PLUMMER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 8 |
| NICOLAS PORTER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 5 |
| MARY ANNE REILLY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| BETH SIMONETTI | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| SUPRIYA TANEJA | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| HAL WALKER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
2017 · 34 people listed · 19 paid, $13.1M · 4,024 employees · 852 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| ALAN F LIST | FORMER EVP-PHYS IN CHIEF | 0 | $0 | $1,453,278 | $334,441 | $1,787,719 | 6 |
| JOHN A KOLOSKY | HOSPITAL PRESIDENT | 23 | $0 | $909,515 | $612,343 | $1,521,858 | 5 |
| G DOUGLAS LETSON | EVP-PHYS IN CHIEF | 15 | $855,339 | $0 | $169,281 | $1,024,620 | 4 |
| YVETTE LYONS TREMONTI | EVP-CFO & ASST TREASURER | 20 | $0 | $745,032 | $215,925 | $960,957 | 2 |
| LOUIS D DE LA PARTE | EVP-GEN COUNSEL, ASST SEC | 20 | $0 | $645,877 | $224,020 | $869,897 | 4 |
| ROBERT KEENAN | VP-QUALITY/CMO | 55 | $661,371 | $0 | $70,963 | $732,334 | 1 |
| SACHIN APTE | ASSOC CHIEF MEDICAL OFFICER | 50 | $635,228 | $0 | $69,673 | $704,901 | 1 |
| BRAULIO VICENTE | SVP-MMG, HOS OPS TO 11/3/17 | 35 | $437,671 | $0 | $259,985 | $697,656 | 2 |
| W MICHAEL ALBERTS | FORMER DIRECTOR, MED DIR MCK | 50 | $370,857 | $0 | $282,633 | $653,490 | 2 |
| JANE FUSILERO | VP-PATIENT CARE SVS/CNO | 55 | $476,591 | $0 | $76,873 | $553,464 | 1 |
| JULIE DJEU | FORMER DIRECTOR, ACD RSCH | 0 | $0 | $405,432 | $116,374 | $521,806 | 1 |
| EDUARDO G MOROS | SR MBR PHYSICIST | 50 | $379,552 | $0 | $128,017 | $507,569 | 1 |
| AMARJIT S SAINI | COORD BRACHYTHERAPY PHYSIC | 50 | $248,155 | $0 | $233,501 | $481,656 | 1 |
| CYNTHIA TERRANO | VP-PAYER STRATEGIES | 35 | $417,775 | $0 | $54,523 | $472,298 | 2 |
| VLADIMIR FEYGELMAN | SR MBR PHYSICIST | 50 | $266,591 | $0 | $200,813 | $467,404 | 1 |
| STUART G WASSERMAN | DIR CLINICAL PHYSICS | 50 | $318,138 | $0 | $135,227 | $453,365 | 1 |
| JOANNA WEISS | VP REV CYCLE MGMT | 35 | $0 | $346,155 | $104,448 | $450,603 | 6 |
| MATT BEDNAR | VP-AMBULATORY OPERATIONS | 55 | $99,355 | $0 | $9,856 | $109,211 | 1 |
| MARILYN COSTACHE | CHIEF RISK OFFICER | 55 | $0 | $71,875 | $10,648 | $82,523 | 1 |
| BETH A HOUGHTON | DIRECTOR, CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| HON MARK A PIZZO | DIRECTOR, VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| JOSEPH CABALLERO | DIRECTOR, SEC/TREAS | 1 | $0 | $0 | $0 | $0 | 4 |
| MICHAEL BICE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| ROLAND DANIELS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| VALERIE GODDARD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| JACQUELINE LEWIS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JO MANION | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JENNIFER MOFFITT | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| KEVIN PLUMMER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 8 |
| NICOLAS PORTER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 5 |
| MARY ANNE REILLY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| BETH SIMONETTI | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| SUPRIYA TANEJA | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| HAL WALKER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
2016 · 35 people listed · 19 paid, $10.8M · 3,802 employees · 837 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| ALAN F LIST | FORMER EVP-PHYS IN CHIEF | 0 | $0 | $1,393,747 | $143,654 | $1,537,401 | 6 |
| JOHN A KOLOSKY | HOSPITAL PRESIDENT | 25 | $0 | $910,725 | $213,791 | $1,124,516 | 5 |
| G DOUGLAS LETSON | EVP-PHYS IN CHIEF | 22 | $795,737 | $0 | $97,407 | $893,144 | 4 |
| YVETTE LYONS TREMONTI | EVP-CFO & ASST TREASURER | 20 | $0 | $661,436 | $73,682 | $735,118 | 2 |
| LOUIS D DE LA PARTE | EVP-GEN COUNSEL, ASST SEC | 20 | $0 | $583,407 | $119,002 | $702,409 | 4 |
| ROBERT KEENAN | VP-QUALITY/CMO | 55 | $604,552 | $0 | $53,160 | $657,712 | 1 |
| BRAULIO VICENTE | SVP-MMG, HOSP OPERATIONS | 35 | $438,418 | $0 | $123,649 | $562,067 | 2 |
| W MICHAEL ALBERTS | FORMER DIRECTOR, MED DIR MCKINLEY | 50 | $400,469 | $0 | $115,123 | $515,592 | 2 |
| JANE FUSILERO | VP-PATIENT CARE SVS/CNO | 55 | $427,769 | $0 | $50,399 | $478,168 | 1 |
| JULIE DJEU | FORMER DIRECTOR, ACD RSCH | 0 | $0 | $408,245 | $65,625 | $473,870 | 1 |
| CYNTHIA TERRANO | VP-PAYER STRATEGIES | 35 | $404,279 | $0 | $42,718 | $446,997 | 2 |
| EDUARDO G MOROS | SR MBR PHYSICIST | 50 | $378,242 | $0 | $62,310 | $440,552 | 1 |
| STUART G WASSERMAN | DIR CLINICAL PHYSICS | 50 | $312,828 | $0 | $77,346 | $390,174 | 1 |
| JOANNA WEISS | VP REV CYCLE MGMT | 35 | $0 | $307,181 | $64,945 | $372,126 | 6 |
| AMARJIT S SAINI | COORD BRACHYTHERAPY PHYSIC | 50 | $255,572 | $0 | $86,825 | $342,397 | 1 |
| VLADIMIR FEYGELMAN | ASSOC MBR PHYSICIST | 50 | $248,683 | $0 | $63,196 | $311,879 | 1 |
| SACHIN APTE | ASSOCIATE CHIEF MEDICAL OFFICER | 50 | $290,807 | $0 | $555 | $291,362 | 1 |
| GENE WETZSTEIN | CHIEF PHARMACY OFFICER THRU 4/2017 | 50 | $228,439 | $0 | $57,867 | $286,306 | 1 |
| VIET HO | MANAGER PHARM-CLINIC 5/2017-6/2017 | 50 | $178,207 | $0 | $55,427 | $233,634 | 1 |
| BETH A HOUGHTON | DIRECTOR, CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HONORABLE MARK A PIZZO | DIRECTOR, VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| JOSEPH CABALLERO | DIRECTOR, SEC/TREAS 10/2016 | 1 | $0 | $0 | $0 | $0 | 4 |
| THE HONORABLE H LEE MOFFITT | DIRECTOR, SEC/TREAS THRU 9/2016 | 1 | $0 | $0 | $0 | $0 | 4 |
| MICHAEL BICE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| ROLAND DANIELS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| VALERIE GODDARD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| JACQUELINE LEWIS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JO MANION | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JENNIFER MOFFITT | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ORLANDO NIEVES | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| KEVIN PLUMMER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 8 |
| NICOLAS PORTER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 5 |
| MARY ANNE REILLY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| SUPRIYA TANEJA | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| HAL WALKER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
2015 · 36 people listed · 21 paid, $12.7M · 3,539 employees · 632 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| ALAN F LIST | FORMER EVP-PHYS IN CHIEF | 0 | $0 | $2,904,711 | $76,128 | $2,980,839 | 6 |
| WILLIAM S DALTON | FORMER PRES/CEO | 0 | $0 | $1,097,768 | $53,801 | $1,151,569 | 5 |
| JOHN A KOLOSKY | HOSPITAL PRESIDENT | 25 | $0 | $942,465 | $94,556 | $1,037,021 | 5 |
| G DOUGLAS LETSON | EVP-PHYS IN CHIEF | 22 | $833,151 | $0 | $49,115 | $882,266 | 4 |
| YVETTE LYONS TREMONTI | EVP-CFO & ASST TREASURER | 20 | $0 | $653,701 | $51,585 | $705,286 | 2 |
| LOUIS D DE LA PARTE | EVP-GEN COUNSEL, ASST SEC | 20 | $0 | $610,363 | $50,636 | $660,999 | 4 |
| ROBERT KEENAN | VP-QUAL & MED AFFAIRS/CMO | 55 | $525,506 | $0 | $11,553 | $537,059 | 1 |
| W MICHAEL ALBERTS | DIRECTOR, MEDICAL DIRECTOR MCKINLEY | 51 | $466,417 | $0 | $44,179 | $510,596 | 2 |
| BRAULIO VICENTE | SVP-HOSP OPERATIONS | 35 | $458,385 | $0 | $48,625 | $507,010 | 2 |
| JULIE DJEU | FORMER DIRECTOR, ACD RSCH EDUC | 0 | $0 | $414,922 | $64,611 | $479,533 | 1 |
| JANE FUSILERO | VP-PATIENT CARE SVS/CNO | 55 | $419,550 | $0 | $37,944 | $457,494 | 1 |
| EDUARDO G MOROS | SR MBR PHYSICIST | 50 | $363,544 | $0 | $49,310 | $412,854 | 1 |
| CYNTHIA TERRANO | VP-PAYER STRATEGIES | 35 | $341,041 | $0 | $3,529 | $344,570 | 2 |
| STUART G WASSERMAN | DIR CLINICAL PHYSICS | 50 | $302,319 | $0 | $41,023 | $343,342 | 1 |
| JOANNA WEISS | VP REV CYCLE MGMT | 35 | $0 | $281,754 | $45,355 | $327,109 | 6 |
| VLADIMIR FEYGELMAN | ASSOC MBR PHYSICIST | 50 | $231,284 | $0 | $39,255 | $270,539 | 1 |
| GENE WETZSTEIN | CHIEF PHARMACY OFFICER | 50 | $229,103 | $0 | $36,178 | $265,281 | 1 |
| AMARJIT S SAINI | COORD BRACHYTHERAPY PHYSIC | 50 | $244,484 | $0 | $12,971 | $257,455 | 1 |
| SIRIPORN SARANGKASIRI | CLINICAL PHYSICIST II | 50 | $225,081 | $0 | $24,410 | $249,491 | 1 |
| SCOTT D ELDREDGE | FORMER KEY EMP, DEPT ADMIN | 50 | $198,245 | $0 | $26,053 | $224,298 | 1 |
| JANENE CULUMBER | FORMER SVP-CFO&ASST TREAS | 0 | $0 | $130,196 | $0 | $130,196 | 4 |
| BETH A HOUGHTON | DIRECTOR, CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HONORABLE MARK A PIZZO | DIRECTOR, VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HONORABLE H LEE MOFFITT | DIRECTOR, SECRETARY/TREAS | 1 | $0 | $0 | $0 | $0 | 4 |
| MICHAEL BICE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| JOSEPH CABALLERO | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 4 |
| ROLAND DANIELS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| VALERIE GODDARD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| JACQUELINE LEWIS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JO MANION | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JENNIFER MOFFITT | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ORLANDO NIEVES | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| KEVIN PLUMMER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 8 |
| NICOLAS PORTER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 5 |
| MARY ANNE REILLY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| HAL WALKER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
2014 · 38 people listed · 24 paid, $11.4M · 3,221 employees · 476 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| ALAN F LIST | FORMER EVP-PHYS IN CHIEF | 0 | $0 | $1,236,229 | $157,192 | $1,393,421 | 6 |
| JOHN A KOLOSKY | HOSPITAL PRESIDENT | 25 | $0 | $891,899 | $214,456 | $1,106,355 | 5 |
| G DOUGLAS LETSON | DIRECTOR, EVP-PHYS IN CHIEF | 22 | $773,665 | $0 | $60,961 | $834,626 | 4 |
| WILLIAM S DALTON | FORMER PRES/CEO | 0 | $0 | $710,012 | $82,332 | $792,344 | 5 |
| YVETTE LYONS TREMONTI | EVP-CFO & ASST TREASURER | 20 | $0 | $586,825 | $95,657 | $682,482 | 2 |
| LOUIS D DE LA PARTE | EVP-GEN COUNSEL, ASST SEC | 20 | $0 | $572,125 | $77,116 | $649,241 | 4 |
| BRAULIO VICENTE | SVP-HOSP OPERATIONS | 35 | $425,189 | $0 | $116,696 | $541,885 | 2 |
| W MICHAEL ALBERTS | DIRECTOR, VP-MED AFFAIRS & CMO TO 12/31/14 | 55 | $447,467 | $0 | $78,117 | $525,584 | 2 |
| MARK F HULSE | FORMER HOSPITAL VP-CIO | 0 | $0 | $457,538 | $64,778 | $522,316 | 4 |
| JANENE CULUMBER | FORMER SVP-CFO&ASST TREAS | 0 | $0 | $452,283 | $49,237 | $501,520 | 4 |
| JANE FUSILERO | VP-PATIENT CARE SVS/CNO | 55 | $382,909 | $0 | $35,868 | $418,777 | 1 |
| EDUARDO G MOROS | SR MBR PHYSICIST | 50 | $359,739 | $0 | $44,166 | $403,905 | 1 |
| W J WILSON | FORMER HOSPITAL VP-GOVT RELATIONS | 0 | $0 | $325,181 | $64,150 | $389,331 | 4 |
| JULIE DJEU | DIRECTOR, ACD RSCH EDUC | 1 | $0 | $306,721 | $63,263 | $369,984 | 1 |
| STUART G WASSERMAN | DIR CLINICAL PHYSICS | 50 | $258,944 | $0 | $39,680 | $298,624 | 1 |
| GENE WETZSTEIN | CHIEF PHARMACY OFFICER | 50 | $204,357 | $0 | $72,709 | $277,066 | 1 |
| VLADIMIR FEYGELMAN | ASSOC MBR PHYSICIST | 50 | $225,225 | $0 | $35,398 | $260,623 | 1 |
| AMARJIT S SAINI | COORD BRACHYTHERAPY PHYSIC | 50 | $232,776 | $0 | $11,606 | $244,382 | 1 |
| SIRIPORN SARANGKASIRI | CLINICAL PHYSICIST II | 50 | $214,065 | $0 | $22,124 | $236,189 | 1 |
| SCOTT D ELDREDGE | FORMER KEY EMP, DEPT ADMIN | 50 | $200,404 | $0 | $30,425 | $230,829 | 1 |
| WILLIAM FRANQUET | VP REV CYCLE MGMT TO 11/10/14 | 35 | $0 | $213,239 | $360 | $213,599 | 2 |
| JOANNA WEISS | VP REV CYCLE MGMT 11/23/2014 | 35 | $0 | $171,780 | $32,676 | $204,456 | 6 |
| DEAN R HEAD | FORMER HOSPITAL VP-FAC MGMT | 0 | $0 | $167,424 | $6,774 | $174,198 | 4 |
| BRENDA S GORDON | FORMER VP-ANCILLARY SVCS | 0 | $126,452 | $0 | $1,897 | $128,349 | 1 |
| BETH A HOUGHTON | DIRECTOR, CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HONORABLE MARK A PIZZO | DIRECTOR, VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HONORABLE H LEE MOFFITT | DIRECTOR, SECRETARY/TREAS | 1 | $0 | $0 | $0 | $0 | 4 |
| MICHAEL BICE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| JOSEPH CABALLERO | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 4 |
| ROLAND DANIELS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| VALERIE GODDARD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| JO MANION | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JENNIFER MOFFITT | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ORLANDO NIEVES | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| CHARLES PAIDAS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| NICOLAS PORTER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 5 |
| MARY ANNE REILLY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT KEENAN | VP-QUAL & MED AFFAIRS/CMO 1/5/2015 | 55 | $0 | $0 | $0 | $0 | 1 |
2013 · 35 people listed · 22 paid, $9.8M · 2,996 employees · 285 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| ALAN F LIST | FORMER EVP-PHYS IN CHIEF | 0 | $0 | $1,193,137 | $53,794 | $1,246,931 | 6 |
| JOHN A KOLOSKY | HOSPITAL PRES | 25 | $0 | $782,603 | $49,523 | $832,126 | 5 |
| G DOUGLAS LETSON | DIRECTOR, EVP-PHYS IN CHIEF | 22 | $651,682 | $0 | $55,601 | $707,283 | 4 |
| WILLIAM S DALTON | FORMER PRES/CEO | 0 | $0 | $650,794 | $32,064 | $682,858 | 5 |
| LOUIS D DE LA PARTE | EVP-GEN COUNSEL, ASST SEC | 20 | $0 | $478,606 | $51,576 | $530,182 | 4 |
| JANENE CULUMBER | SVP-CFO&ASST TREAS TO 2/1/14;FIN&PAY STRAT 2/2/14 | 21 | $0 | $437,595 | $49,983 | $487,578 | 4 |
| YVETTE LYONS TREMONTI | EVP-ST&BUS DEV;CFO&ASST TREA 2/2/14 | 21 | $0 | $422,671 | $55,431 | $478,102 | 2 |
| W MICHAEL ALBERTS | DIRECTOR, VP-MED AFFAIRS/CMO | 55 | $399,498 | $0 | $53,550 | $453,048 | 2 |
| BRAULIO VICENTE | SVP-HOSP OPERATIONS | 35 | $384,002 | $0 | $49,766 | $433,768 | 2 |
| EDUARDO G MOROS | SR MBR PHYSICIST | 50 | $347,302 | $0 | $55,365 | $402,667 | 1 |
| MARK F HULSE | FORMER HOSPITAL VP-CIO | 0 | $0 | $336,830 | $49,158 | $385,988 | 4 |
| JANE FUSILERO | VP-PATIENT CARE SVS/CNO | 55 | $336,008 | $0 | $42,950 | $378,958 | 1 |
| JULIE DJEU | DIRECTOR, ACD RSCH EDUC | 1 | $0 | $302,899 | $49,604 | $352,503 | 1 |
| W J WILSON | FORMER HOSPITAL VP-GOVT RE | 0 | $0 | $291,312 | $45,274 | $336,586 | 4 |
| BRENDA S GORDON | VP-ANCILLARY SVCS | 55 | $299,052 | $0 | $23,429 | $322,481 | 1 |
| STUART G WASSERMAN | DIR CLINICAL PHYSICS | 50 | $260,515 | $0 | $45,755 | $306,270 | 1 |
| VLADIMIR FEYGELMAN | ASSOC MBR PHYSICIST | 50 | $222,524 | $0 | $47,114 | $269,638 | 1 |
| AMARJIT S SAINI | COORD BRACHYTHERAPY PHYSIC | 50 | $227,304 | $0 | $25,530 | $252,834 | 1 |
| DEAN R HEAD | FORMER HOSPITAL VP-FAC MGM | 0 | $0 | $223,310 | $25,679 | $248,989 | 4 |
| SIRIPORN SARANGKASIRI | CLINICAL PHYSICIST II | 50 | $214,868 | $0 | $33,283 | $248,151 | 1 |
| GENE WETZSTEIN | DIR PHARMACY | 50 | $201,505 | $0 | $41,356 | $242,861 | 1 |
| SCOTT D ELDREDGE | FORMER KEY EMP, DEPT ADMIN | 50 | $179,693 | $0 | $29,858 | $209,551 | 1 |
| BETH A HOUGHTON | DIRECTOR, CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HONORABLE MARK A PIZZO | DIRECTOR, VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HONORABLE H LEE MOFFITT | DIRECTOR, SECRETARY/TREASURER | 1 | $0 | $0 | $0 | $0 | 4 |
| MICHAEL BICE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| JOSEPH CABALLERO | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 4 |
| ROLAND DANIELS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| VALERIE GODDARD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| STEPHEN K KLASKO MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ORLANDO NIEVES | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| CHARLES PAIDAS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| NICOLAS PORTER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 5 |
| MARY ANNE REILLY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| WILLIAM FRANQUET | VP REV CYCLE MGMT AS OF 1/6/2014 | 35 | $0 | $0 | $0 | $0 | 2 |
2012 · 33 people listed · 22 paid, $9.0M · 2,899 employees · 707 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| WILLIAM S DALTON | FORMER PRES/CEO | 0 | $0 | $1,082,849 | $44,981 | $1,127,830 | 5 |
| ALAN F LIST | EVP-PHYS IN CHIEF TO 7/25/12 | 15 | $405,452 | $320,050 | $45,389 | $770,891 | 6 |
| JOHN A KOLOSKY | HOSPITAL PRES | 32 | $0 | $654,465 | $45,876 | $700,341 | 5 |
| G DOUGLAS LETSON | EVP-PHYS IN CHIEF 7/26/12 | 23 | $260,666 | $307,869 | $45,952 | $614,487 | 4 |
| LOUIS D DE LA PARTE | EVP-GEN COUNSEL, ASST SEC | 22 | $0 | $490,687 | $40,001 | $530,688 | 4 |
| JANENE CULUMBER | SVP-CFO, ASST TREASURER | 22 | $0 | $398,066 | $34,768 | $432,834 | 4 |
| W MICHAEL ALBERTS | DIRECTOR, VP-MED AFFAIRS | 55 | $376,855 | $0 | $46,830 | $423,685 | 2 |
| BRAULIO VICENTE | SVP-HOSP OPERATIONS | 48 | $378,766 | $0 | $40,957 | $419,723 | 2 |
| YVETTE LYONS TREMONTI | EVP-STRATEGY & BUS DEVEL | 32 | $0 | $351,262 | $50,456 | $401,718 | 2 |
| EDUARDO G MOROS | SR MBR PHYSICIST | 55 | $345,453 | $0 | $37,530 | $382,983 | 1 |
| MARK F HULSE | FORMER HOSPITAL VP-CIO | 0 | $0 | $314,124 | $39,989 | $354,113 | 4 |
| JANE FUSILERO | VP-PATIENT CARE SVS/CNO | 55 | $296,841 | $0 | $34,082 | $330,923 | 1 |
| JULIE DJEU | DIRECTOR, SR MBR FAC RSCH | 1 | $0 | $273,448 | $40,450 | $313,898 | 1 |
| W J WILSON | FORMER HOSPITAL VP-GOVT REL | 0 | $0 | $255,407 | $30,803 | $286,210 | 4 |
| BRENDA S GORDON | VP-ANCILLARY SVCS | 55 | $248,453 | $0 | $24,804 | $273,257 | 1 |
| STUART G WASSERMAN | DIR CLINICAL PHYSICS | 55 | $235,508 | $0 | $30,341 | $265,849 | 1 |
| VLADIMIR FEYGELMAN | ASSOC MBR PHYSICIST | 55 | $217,739 | $0 | $37,111 | $254,850 | 1 |
| AMARJIT S SAINI | COORD BRACHYTHERAPY PHYSICS | 55 | $227,929 | $0 | $14,975 | $242,904 | 1 |
| SIRIPORN SARANGKASIRI | CLINICAL PHYSICIST II | 55 | $213,377 | $0 | $21,949 | $235,326 | 1 |
| DEAN R HEAD | FORMER HOSPITAL VP-FAC MGMT | 0 | $0 | $210,225 | $24,155 | $234,380 | 4 |
| GENE WETZSTEIN | DIR PHARMACY | 55 | $186,407 | $0 | $35,339 | $221,746 | 1 |
| SCOTT D ELDREDGE | FORMER KEY EMP, DEPT ADMIN | 55 | $193,253 | $0 | $19,450 | $212,703 | 1 |
| BETH A HOUGHTON | CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HONORABLE MARK A PIZZO | VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HONORABLE H LEE MOFFITT | SECRETARY/TREASURER | 1 | $0 | $0 | $0 | $0 | 4 |
| JOSEPH CABALLERO | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 4 |
| VALERIE GODDARD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| DWAYNE HAWKINS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| RONALD A HURST | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| STEPHEN K KLASKO MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ORLANDO NIEVES | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| CHARLES PAIDAS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MARY ANNE REILLY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
2011 · 38 people listed · 25 paid, $10.6M · 2,844 employees · 689 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| WILLIAM S DALTON | FORMER PRES/CEO | 0 | $0 | $1,283,434 | $75,263 | $1,358,697 | 5 |
| JOHN A KOLOSKY | HOSPITAL PRES | 33 | $0 | $776,151 | $43,734 | $819,885 | 5 |
| ALAN F LIST | EVP-PHYSICIAN IN CHIEF | 30 | $679,052 | $0 | $42,871 | $721,923 | 6 |
| THOMAS A SELLERS | FORMER EVP-ACD CANCER | 0 | $0 | $621,238 | $47,380 | $668,618 | 5 |
| NICOLAS C PORTER | FORMER EVP-INST ADV & CORP | 0 | $0 | $554,253 | $40,029 | $594,282 | 5 |
| LOUIS D DE LA PARTE | EVP-GEN COUNSEL, ASST SEC | 22 | $0 | $472,514 | $39,484 | $511,998 | 4 |
| JANENE CULUMBER | VP-CFO, ASST TREASURER | 22 | $0 | $456,168 | $35,159 | $491,327 | 4 |
| W MICHAEL ALBERTS | DIRECTOR, VP-MED AFFAIRS CMO | 55 | $430,071 | $0 | $44,513 | $474,584 | 2 |
| BRAULIO VICENTE | SVP-HOSP OPERATIONS | 48 | $392,600 | $0 | $44,121 | $436,721 | 2 |
| YVETTE LYONS TREMONTI | EVP-STRATEGY & BUS DEVEL | 32 | $0 | $365,086 | $43,146 | $408,232 | 2 |
| MARK F HULSE | FORMER HOSPITAL VP-CIO | 0 | $0 | $317,987 | $37,128 | $355,115 | 4 |
| JULIE DJEU | DIRECTOR, SR MBR FAC RSCH | 1 | $0 | $284,038 | $36,166 | $320,204 | 1 |
| STUART G WASSERMAN | DIR CLINICAL PHYSICS | 55 | $269,357 | $0 | $34,448 | $303,805 | 1 |
| W J WILSON | FORMER HOSPITAL VP-GOVT RE | 0 | $0 | $273,699 | $27,036 | $300,735 | 4 |
| BRENDA S GORDON | VP-ANCILLARY SVCS | 55 | $273,899 | $0 | $23,232 | $297,131 | 1 |
| KENNETH M FORSTER | ASSOC MBR PHYSICIST | 55 | $253,214 | $0 | $41,617 | $294,831 | 1 |
| MARYBETH REARDON | FORMER VP-PAT CARE SVS/CNO | 55 | $262,093 | $0 | $26,837 | $288,930 | 1 |
| JANE FUSILERO | VP-PATIENT CARE SVS/CNO | 55 | $257,615 | $0 | $9,016 | $266,631 | 1 |
| DEAN R HEAD | FORMER HOSPITAL VP-FAC MGM | 0 | $0 | $233,893 | $26,416 | $260,309 | 4 |
| VLADIMIR FEYGELMAN | ASSOC MBR PHYSICIST | 55 | $221,463 | $0 | $34,280 | $255,743 | 1 |
| BRIAN K NORIEGA | CLINICAL PHYSICIST II | 55 | $214,018 | $0 | $30,141 | $244,159 | 1 |
| SIRIPORN SARANGKASIRI | CLINICAL PHYSICIST II | 55 | $216,387 | $0 | $21,071 | $237,458 | 1 |
| GENE WETZSTEIN | DIR PHARMACY | 55 | $198,912 | $0 | $37,143 | $236,055 | 1 |
| SCOTT D ELDREDGE | FORMER KEY EMP, DEPT ADMIN | 55 | $197,582 | $0 | $21,353 | $218,935 | 1 |
| PHILIP E JOHNSON | FORMER DIR PHARMACY | 55 | $193,262 | $0 | $19,343 | $212,605 | 1 |
| BETH A HOUGHTON | CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HONORABLE MARK A PIZZO | VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HONORABLE H LEE MOFFITT | SECRETARY/TREASURER | 1 | $0 | $0 | $0 | $0 | 4 |
| KAREN A ARNOLD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 5 |
| JOSEPH CABALLERO | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 4 |
| VALERIE GODDARD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| HARVEY M GREENBERG MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| DWAYNE HAWKINS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| RONALD A HURST | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| STEPHEN K KLASKO MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ORLANDO NIEVES | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| CHARLES PAIDAS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MARY ANNE REILLY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
2010 · 38 people listed · 24 paid, $9.9M · 2,726 employees · 735 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| WILLIAM S DALTON | PRES/CEO & CTR DIRECT-PARENT | 1 | $0 | $1,314,151 | $67,154 | $1,381,305 | 5 |
| JOHN A KOLOSKY | HOSP PRES AS OF 2/11/11 | 33 | $0 | $725,119 | $43,330 | $768,449 | 5 |
| ALAN F LIST | EVP-PHYSICIAN IN CHIEF | 33 | $309,464 | $336,120 | $43,267 | $688,851 | 6 |
| NICOLAS C PORTER | EVP-INST ADV & CORP REL | 33 | $0 | $574,354 | $39,695 | $614,049 | 5 |
| THOMAS A SELLERS | FORMER EVP-ACD CANCER | 0 | $0 | $561,879 | $47,650 | $609,529 | 5 |
| LOUIS D DE LA PARTE | EVP-GEN COUNSEL, ASST SEC | 22 | $0 | $465,035 | $39,330 | $504,365 | 4 |
| W MICHAEL ALBERTS | DIRECTOR, VP-MEDICAL AFFAIRS | 55 | $205,414 | $217,993 | $44,228 | $467,635 | 2 |
| JANENE CULUMBER | VP-CFO, ASST TREASURER | 22 | $0 | $394,396 | $34,904 | $429,300 | 4 |
| BRAULIO VICENTE | SVP-HOSP OPERATIONS | 40 | $358,349 | $0 | $42,361 | $400,710 | 2 |
| YVETTE LYONS TREMONTI | EVP-STRATEGY & BUS DEVEL | 33 | $0 | $302,801 | $37,774 | $340,575 | 2 |
| MARK F HULSE | FORMER HOSPITAL VP-CIO | 0 | $0 | $285,574 | $33,600 | $319,174 | 4 |
| W J WILSON | FORMER HOSPITAL VP-GOVT REL | 22 | $108,994 | $177,270 | $26,240 | $312,504 | 4 |
| JULIE DJEU | DIRECTOR, SR MBR FAC RSCH | 1 | $0 | $286,155 | $25,870 | $312,025 | 1 |
| MARYBETH REARDON | VP-PATIENT CARE SVS/CNO | 55 | $272,353 | $0 | $26,606 | $298,959 | 1 |
| KENNETH M FORSTER | ASSOC MBR PHYSICIST | 55 | $252,484 | $0 | $39,642 | $292,126 | 1 |
| STUART G WASSERMAN | DIR CLINICAL PHYSICS | 55 | $241,048 | $0 | $33,449 | $274,497 | 1 |
| BRENDA S GORDON | VP-ANCILLARY SVCS | 55 | $249,376 | $0 | $22,775 | $272,151 | 1 |
| VLADIMIR FEYGELMAN | ASSIST MBR PHYSICIST | 55 | $223,775 | $0 | $30,470 | $254,245 | 1 |
| BRIAN K NORIEGA | CLINICAL PHYSICIST II | 55 | $209,039 | $0 | $31,500 | $240,539 | 1 |
| DEAN R HEAD | FORMER HOSPITAL VP-FAC MGMT | 0 | $0 | $206,862 | $26,423 | $233,285 | 4 |
| SIRIPORN SARANGKASIRI | CLINICAL PHYSICIST II | 55 | $212,077 | $0 | $21,071 | $233,148 | 1 |
| PHILIP E JOHNSON | FORMER DIR PHARMACY | 55 | $199,812 | $0 | $24,757 | $224,569 | 1 |
| GENE WETZSTEIN | DIR PHARMACY | 55 | $185,010 | $0 | $34,753 | $219,763 | 1 |
| SCOTT D ELDREDGE | DEPARTMENT ADMINSTRATOR | 55 | $186,385 | $0 | $23,458 | $209,843 | 1 |
| BETH A HOUGHTON | CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HONORABLE MARK A PIZZO | VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HONORABLE H LEE MOFFITT | SECRETARY/TREASURER | 1 | $0 | $0 | $0 | $0 | 4 |
| KAREN A ARNOLD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 5 |
| JOSEPH CABALLERO | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 4 |
| MUNYA CHIURA PHD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| HARVEY M GREENBERG MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| DWAYNE HAWKINS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| RONALD A HURST | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| STEPHEN K KLASKO MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| THE HONORABLE GWEN MILLER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ORLANDO NIEVES | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| MARY ANNE REILLY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JANE FUSILERO | VP-PATIENT CARE SVS/CNO | 55 | $0 | $0 | $0 | $0 | 1 |
2009 · 36 people listed · 24 paid, $8.4M · 2,581 employees · 400 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| WILLIAM S DALTON | PRES/CEO & CTR DIRECTOR | 40 | $0 | $1,032,396 | $40,756 | $1,073,152 | 5 |
| JOHN A KOLOSKY | EXEC VP/COO | 40 | $0 | $667,836 | $47,071 | $714,907 | 5 |
| ALAN F LIST | EXEC VP PHYSICIAN IN CHIEF | 40 | $0 | $522,633 | $43,375 | $566,008 | 6 |
| NICOLAS C PORTER | EXEC VP INST ADV/CO REL | 40 | $0 | $487,527 | $54,177 | $541,704 | 5 |
| THOMAS A SELLERS | FORMER EXEC VP/ACD CANCER | 40 | $0 | $463,530 | $49,455 | $512,985 | 5 |
| LOUIS D DE LA PARTE | ASST SECRETARY, EVP-GEN COUNSEL | 40 | $0 | $385,088 | $39,756 | $424,844 | 4 |
| W MICHAEL ALBERTS | CHIEF MEDICAL OFFICER | 40 | $0 | $372,270 | $44,337 | $416,607 | 2 |
| JANENE CULUMBER | ASST TREASURER, VP/CFO | 40 | $0 | $289,872 | $32,816 | $322,688 | 4 |
| BRAULIO VICENTE | SVP HOSP & PHYSICIAN GRP O | 40 | $135,056 | $142,875 | $42,453 | $320,384 | 2 |
| JULIE DJEU | DIRECTOR | 1 | $0 | $289,246 | $25,602 | $314,848 | 1 |
| KENNETH M FORSTER | ASSOCIATE MEMBER FACULTY C | 40 | $268,408 | $0 | $38,849 | $307,257 | 1 |
| YVETTE LYONS TREMONTI | VP HUMAN RESOURCES | 40 | $0 | $249,143 | $29,459 | $278,602 | 2 |
| W J WILSON | VP STRATEGIC COMM/PUB AFFA | 40 | $234,346 | $0 | $24,634 | $258,980 | 4 |
| VLADIMIR FEYGELMAN | ASSISTANT MEMBER FACULTY C | 40 | $216,598 | $0 | $29,518 | $246,116 | 1 |
| MARY E REARDON | VP PATIENT CARE SERVICES/C | 40 | $243,019 | $0 | $2,558 | $245,577 | 1 |
| STUART G WASSERMAN | DIR CLINICAL PHYSICS | 40 | $216,389 | $0 | $23,440 | $239,829 | 1 |
| BRIAN K NORIEGA | CLINICAL PHYSICIST | 40 | $206,568 | $0 | $29,636 | $236,204 | 1 |
| SIRIPORN SARANGKASIRI | CLINICAL PHYSICIST | 40 | $210,477 | $0 | $18,809 | $229,286 | 1 |
| BRENDA S GORDON | VP ANCILLARY SVCS | 40 | $203,909 | $0 | $19,555 | $223,464 | 1 |
| PHILIP E JOHNSON | DIR PHARMACY | 40 | $201,367 | $0 | $21,627 | $222,994 | 1 |
| MARK F HULSE | VP & CIO | 40 | $0 | $197,311 | $5,136 | $202,447 | 4 |
| KELLY HALL | VP/FACULTY AFFAIRS | 40 | $29,650 | $148,967 | $10,003 | $188,620 | 2 |
| SCOTT D ELDREDGE | DEPARTMENT ADMINSTRATOR | 40 | $166,654 | $0 | $17,020 | $183,674 | 1 |
| DEAN R HEAD | VP FACILITIES MGMT & CONST | 40 | $63,725 | $92,485 | $19,169 | $175,379 | 4 |
| BETH A HOUGHTON | CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HONORABLE MARK A PIZZO | VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| THE HONORABLE H LEE MOFFITT | SECRETARY/TREASURER | 1 | $0 | $0 | $0 | $0 | 4 |
| KAREN A ARNOLD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 5 |
| JOSEPH CABALLERO | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 4 |
| MUNYA CHIURA PHD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| HARVEY M GREENBERG MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| DWAYNE HAWKINS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| RONALD A HURST | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| STEPHEN K KLASKO MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| THE HONORABLE GWEN MILLER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MARY ANNE REILLY | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
Highest-paid independent contractors
2024 · 5 contractors · $27.6M
| Name | Location | Service | Paid |
|---|---|---|---|
| NATIONAL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | DONOR SEARCH SERVICES | $13,978,445 |
| UNIVERSITY DIAGNOSTIC INST | TAMPA, FL | MRI SERVICES | $5,686,214 |
| SODEXO INC & AFFILIATES | NORTH BETHESDA, MD | FOOD SERVICES | $3,185,262 |
| ASSOC REGIONAL & UNIV PATH | SALT LAKE CITY, UT | LABORATORY SERVICES | $2,821,461 |
| BARR & BARR INC | NEW YORK, NY | PROFESSIONAL SERVICES | $1,942,662 |
2023 · 5 contractors · $26.0M
| Name | Location | Service | Paid |
|---|---|---|---|
| NATIONAL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | DONOR SEARCH SERVICES | $11,878,445 |
| UNIVERSITY DIAGNOSTIC INST | TAMPA, FL | MRI SERVICES | $5,530,179 |
| AYA HEALTHCARE INC | SAN DIEGO, CA | HEALTHCARE STAFFING SERVICES | $3,336,816 |
| SODEXO INC & AFFILIATES | NORTH BETHESDA, MD | FOOD SERVICES | $2,725,092 |
| ASSOC REGIONAL & UNIV PATH | SALT LAKE CITY, UT | LABORATORY SERVICES | $2,531,221 |
2022 · 5 contractors · $36.5M
| Name | Location | Service | Paid |
|---|---|---|---|
| AYA HEALTHCARE INC | SAN DIEGO, CA | HEALTHCARE STAFFING SERVICES | $11,700,983 |
| NATIONAL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | DONOR SEARCH SERVICES | $9,567,155 |
| RN NETWORK | BOCA RATON, FL | RECRUITMENT SERVICES | $7,395,183 |
| UNIVERSITY DIAGNOSTIC INST | TAMPA, FL | MRI SERVICES | $5,524,711 |
| ASSOC REGIONAL & UNIV PATH | SALT LAKE CITY, UT | LABORATORY SERVICES | $2,333,376 |
2021 · 5 contractors · $27.4M
| Name | Location | Service | Paid |
|---|---|---|---|
| NATIONAL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | DONOR SEARCH SERVICES | $9,170,983 |
| USF COLLEGE OF MEDICINE | TAMPA, FL | MEDICAL SERVICES | $5,441,558 |
| UNIVERSITY DIAGNOSTIC INST | TAMPA, FL | MRI SERVICES | $5,256,738 |
| RN NETWORK | BOCA RATON, FL | RECRUITMENT SERVICES | $4,494,523 |
| WHITING-TURNER CONTRACTING | TAMPA, FL | CONSTRUCTION MANAGEMENT | $3,053,727 |
2020 · 5 contractors · $18.0M
| Name | Location | Service | Paid |
|---|---|---|---|
| NATIONAL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | DONOR SEARCH SERVICES | $8,301,663 |
| UNIVERSITY DIAGNOSTIC INST | TAMPA, FL | MRI SERVICES | $3,906,821 |
| BARR & BARR INC | TAMPA, FL | PROFESSIONAL SERVICES | $2,169,691 |
| ERNST & YOUNG LLP | SECAUCUS, NJ | PROFESSIONAL SERVICES | $1,878,448 |
| ASSOC REGIONAL & UNIV PATH | TAMPSALT LAKE CITYA, UT | LABORATORY SERVICES | $1,756,536 |
2019 · 5 contractors · $12.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| NATIONAL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | DONOR SEARCH SERVICES | $6,769,650 |
| ASSOC REGIONAL & UNIV PATH | TAMPSALT LAKE CITYA, UT | LABORATORY SERVICES | $1,873,348 |
| UNIVERSITY DIAGNOSTIC INST | TTAMPA, FL | MRI SERVICES | $1,557,063 |
| THE CHARTIS GROUP LLC | CHICAGOCHICAGO, IL | CONSULTING SERVICES | $1,038,670 |
| AMN HEALTHCARE INC | SAN DIEGO, CA | TEMPORARY LABOR SERVICES | $912,030 |
2018 · 5 contractors · $13.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| NATIONAL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | DONOR SEARCH SERVICES | $6,681,005 |
| HARMONY HEALTHCARE | TAMPA, FL | TEMPORARY LABOR | $2,073,628 |
| LEIDOS HEALTH LLC | PITTSBURGH, PA | CONSULTING SERVICES | $1,735,021 |
| ASSOC REGIONAL & UNIV PATH | SALT LAKE CITY, UT | LABORATORY SERVICES | $1,513,023 |
| SODEXO INC & AFFILIATES | GAITHERSBURG, MD | FOOD MANAGEMENT | $1,089,879 |
2017 · 5 contractors · $13.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| NATIONAL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | DONOR SEARCH SERVICE | $7,227,221 |
| LEIDOS HEALTH LLC | PITTSBURGH, PA | CONSULTING SERVICES | $2,462,358 |
| ASSOC REGIONAL UNIV PATH | SALT LAKE CITY, UT | LABORATORY SERVICES | $1,910,065 |
| SODEXO INC AFFILIATES | GAITHERSBURG, MD | CAFETERIA SERVICES | $1,265,648 |
| HARMONY HEALTHCARE | TAMPA, FL | TEMPORARY LABOR | $1,028,380 |
2016 · 5 contractors · $13.4M
| Name | Location | Service | Paid |
|---|---|---|---|
| NATIONAL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | DONOR SEARCH SERVICES | $6,604,933 |
| ASSOC REGIONAL & UNIV PATH | SALT LAKE CITY, UT | LABORATORY SERVICES | $1,952,091 |
| LEIDOS HEALTH LLC | PITTSBURGH, PA | CONSULTING SERVICES | $1,842,299 |
| HARMONY HEALTHCARE | TAMPA, FL | TEMPORARY LABOR | $1,654,900 |
| HURON CONSULTING SERVICES LLC | CHICAGO, IL | CONSULTING SERVICES | $1,313,135 |
2015 · 5 contractors · $5.4M
| Name | Location | Service | Paid |
|---|---|---|---|
| LEIDOS HEALTH LLC | PITTSBURGH, PA | PROFESSIONAL SERVICES | $2,425,715 |
| LAB CORP OF AMERICA | BURLINGTON, NC | LAB SERVICES | $1,184,285 |
| HARMONY HEALTHCARE | TAMPA, FL | PROFESSIONAL SERVICES | $978,090 |
| LOCUMTENENSCOM | ATLANTA, GA | PROFESSIONAL SERVICES | $484,993 |
| THIRD EYE TELERADIOLOGY LLC | AUSTIN, TX | RADIOLOGY SERVICES | $356,800 |
2014 · 5 contractors · $4.6M
| Name | Location | Service | Paid |
|---|---|---|---|
| LEIDOS HEALTH LLC | PITTSBURGH, PA | PROFESSIONAL SERVICES | $1,099,819 |
| LAB CORP OF AMERICA | BURLINGTON, NC | LAB SERVICES | $1,055,056 |
| HARMONY HEALTHCARE | TAMPA, FL | PROFESSIONAL SERVICES | $892,711 |
| LOCUMTENENSCOM | ATLANTA, GA | PROFESSIONAL SERVICES | $845,056 |
| MEDCYCLE MANAGEMENT | BRENTWOOD, TN | COLLECTIONS | $730,852 |
2013 · 5 contractors · $2.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| LAB CORP OF AMERICA | LAB SERVICES | $1,253,825 | |
| MEDCYCLE MANAGEMENT | COLLECTIONS | $239,630 | |
| MEDICAL DOCTOR ASSOC | STAFFING | $224,409 | |
| MEDICAL STAFFING NETWORK | STAFFING | $223,159 | |
| HILL WARD & HENDERSON | LEGAL SERVICES | $195,817 |
2012 · 4 contractors · $1.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| LAB CORP OF AMERICA | BURLINGTON, NC | LAB SERVICES | $668,079 |
| PRECYSE SOLUTIONS LLC | WAYNE, PA | CONSULTING SERVICES | $231,522 |
| DELOITTE CONSULTING LLP | HERMITAGE, TN | CONSULTING SERVICES | $170,000 |
| THERMACIRC LLC | OLDSMAR, FL | CHEMOPERFUSION SERVICES | $164,175 |
2011 · 5 contractors · $4.6M
| Name | Location | Service | Paid |
|---|---|---|---|
| DELOITTE CONSULTING LLP | HERMITAGE, TN | CONSULTING SERVICES | $2,174,576 |
| PRECYSE SOLUTIONS LLC | WAYNE, PA | CONSULTING SERVICES | $1,416,916 |
| LAB CORP OF AMERICA | BURLINGTON, NC | LAB SERVICES | $501,442 |
| CSC CONSULTING INC | FALLS CHURCH, VA | CONSULTING SERVICES | $307,630 |
| THERMACIRC LLC | OLDSMAR, FL | CHEMOPERFUSION SERVICES | $174,725 |
2010 · 5 contractors · $1.3M
| Name | Location | Service | Paid |
|---|---|---|---|
| LAB CORP OF AMERICA | BURLINGTON, NC | LAB SERVICES | $450,161 |
| ERNST & YOUNG US LLP | SECAUCUS, NJ | AUDIT AND TAX SERVICES | $269,738 |
| CUMMINS POWER SOUTH LLC | ATLANTA, GA | CONSTRUCTION SERVICES | $232,448 |
| THERMACIRC LLC | OLDSMAR, FL | EQUIPMENT SERVICES | $192,940 |
| LIBERTY PARTNERS GROUP LLP | WASHINGTON, DC | CONSULTING SERVICES | $150,413 |
2009 · 5 contractors · $1.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| ERNST & YOUNG US LLP | SECAUCUS, NJ | AUDIT AND TAX SERVICES | $268,410 |
| CUMMINS POWER SOUTH LLC | ATLANTA, GA | CONSTRUCTION SERVICES | $245,135 |
| AULT INTL MEDICAL MGMT LLC | COLUMBUS, OH | BENEFITS MANAGEMENT SERVICES | $233,540 |
| TAMPA BAY RAYS BASEBALL LTD | ST PETERSBURG, FL | SPONSORSHIP | $163,521 |
| RARNA LLC | TAMPA, FL | CONSULTING SERVICES | $157,680 |
Who the money went to
Grants this organization reported paying: Schedule I Part II of the Form 990, or the grants-paid list on the 990-PF. Open a year for every recipient. Recipients link to their own page when the grant names an EIN we have (990-PF grants list no EIN, so those link only on an exact, unique name and state). Grants to individuals are counted; their names are not shown.
2024 · 3 grants to organizations · $19.1M
2023 · 2 grants to organizations · $20.6M
2022 · 2 grants to organizations · $20.7M
2021 · 3 grants to organizations · $10.6M
2020 · 1 grant to organizations · $10.6M
2019 · 1 grant to organizations · $7.7M
2018 · 2 grants to organizations · $10.6M
2017 · 1 grant to organizations · $2.6M
2016 · 1 grant to organizations · $3.7M
2014 · 1 grant to organizations · $12.6M
2013 · 2 grants to organizations · $10.6M
2012 · 2 grants to organizations · $10.6M
2011 · 3 grants to organizations · $9.3M
2009 · 5 grants to organizations · $66K
Listed grants add up to $65,800; the return's “grants paid” expense line says $141,450. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
Negative amounts are returned or refunded grants; they are listed last and left out of the totals of grants paid.
Who gave
Contributor names are not public for this form type.
Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.
Finances
Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.
| Revenue | Expenses | Assets | Net assets | Contributions | Program revenue | Officer pay | Employees | Volunteers |
|---|---|---|---|---|---|---|---|---|
| 2024 · Form 990 | ||||||||
| $2,640,684,525 | $2,186,992,097 | $517,116,702 | $371,724,483 | $32,014,184 | $2,607,412,487 | $5,393,844 | 6,726 | 848 |
| 2023 · Form 990 | ||||||||
| $2,266,093,525 | $1,863,950,104 | $457,172,681 | $328,033,802 | $25,372,698 | $2,238,321,568 | $4,626,748 | 6,256 | 672 |
| 2022 · Form 990 | ||||||||
| $2,024,751,052 | $1,622,473,343 | $392,759,623 | $286,725,431 | $20,397,306 | $2,002,650,392 | $3,888,509 | 5,471 | 570 |
| 2021 · Form 990 | ||||||||
| $1,753,776,154 | $1,409,693,924 | $351,948,718 | $247,266,020 | $17,046,893 | $1,735,806,498 | $3,729,491 | 5,198 | 629 |
| 2020 · Form 990 | ||||||||
| $1,529,253,212 | $1,233,194,674 | $306,961,963 | $189,319,358 | $18,277,042 | $1,509,241,139 | $4,026,214 | 4,762 | 465 |
| 2019 · Form 990 | ||||||||
| $1,369,161,087 | $1,080,580,709 | $286,006,622 | $198,847,498 | $41,081,644 | $1,326,798,964 | $3,723,267 | 4,488 | 803 |
| 2018 · Form 990 | ||||||||
| $1,262,183,814 | $1,017,284,444 | $274,999,134 | $214,815,328 | $24,718,713 | $1,236,041,531 | $3,439,128 | 4,199 | 882 |
| 2017 · Form 990 | ||||||||
| $1,042,592,797 | $874,970,844 | $215,935,906 | $168,633,768 | $13,341,848 | $1,028,462,216 | $3,552,024 | 4,024 | 852 |
| 2016 · Form 990 | ||||||||
| $925,040,784 | $781,216,193 | $185,909,533 | $119,343,409 | $14,143,313 | $910,107,573 | $4,289,153 | 3,802 | 837 |
| 2015 · Form 990 | ||||||||
| $817,462,649 | $700,127,638 | $162,071,983 | $110,886,663 | $10,663,909 | $804,486,683 | $3,691,410 | 3,539 | 632 |
| 2014 · Form 990 | ||||||||
| $764,956,946 | $651,431,428 | $141,481,633 | $86,399,145 | $7,224,360 | $754,476,547 | $3,015,935 | 3,221 | 476 |
| 2013 · Form 990 | ||||||||
| $715,755,248 | $606,351,225 | $135,008,983 | $86,049,010 | $8,687,447 | $702,928,667 | $2,976,561 | 2,996 | 285 |
| 2012 · Form 990 | ||||||||
| $640,603,492 | $564,442,968 | $112,736,878 | $68,926,905 | $6,143,920 | $630,566,541 | $2,760,064 | 2,899 | 707 |
| 2011 · Form 990 | ||||||||
| $606,326,220 | $562,502,915 | $125,951,439 | $96,083,043 | $5,365,311 | $597,186,596 | $2,855,687 | 2,844 | 689 |
| 2010 · Form 990 | ||||||||
| $566,177,014 | $509,664,148 | $129,567,820 | $94,052,747 | $3,536,511 | $559,022,885 | $3,056,621 | 2,726 | 735 |
| 2009 · Form 990 | ||||||||
| $528,443,222 | $460,246,141 | $325,027,437 | $280,918,193 | $7,551,785 | $514,831,626 | $1,726,031 | 2,581 | 400 |
Connected to
Organizations that list some of the same people on their returns (officers, directors, key employees on this organization’s latest return), and related organizations it lists on Schedule R.
- H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC Tampa, FL · 17 people in common (Beth A Houghton, Charles Fletcher, Evan Zaslow) · related organization (Schedule R)
- H LEE MOFFITT CANCER CTR & RES INST LIFE TIME CANCER SCRN CTR INC Tampa, FL · 13 people in common (Charles Fletcher, Evan Zaslow, G Douglas Letson) · related organization (Schedule R)
- H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION INC Tampa, FL · 8 people in common (Charles Fletcher, Joanna Weiss, Joseph Caballero) · related organization (Schedule R)
- MOFFITT LIFESCIENCES CAMPUS MANAGEMENT CORPORATION Tampa, FL · 6 people in common (Charles Fletcher, Henry Reyes, Joanna Weiss) · related organization (Schedule R)
- MOFFITT REAL ESTATE HOLDING CORPORATION Tampa, FL · 6 people in common (Charles Fletcher, Joanna Weiss, L David De La Parte) · related organization (Schedule R)
- NATIONAL COMPREHENSIVE CANCER NETWORK INC Plymouth Mtng, PA · 2 people in common (G Douglas Letson, Nicolas Porter)
- TAMPA BAY PERFORMING ARTS CENTER Tampa, FL · 1 person in common (Kevin Plummer)
- TAMPA BAY CONVENTION & VISITORS BUREAU INC Tampa, FL · 1 person in common (Joseph Caballero)
- FLORIDA WEST COAST PUBLIC BROADCASTING INC Tampa, FL · 1 person in common (Kevin Plummer)
- TAMPA PREPARATORY SCHOOL INC Tampa, FL · 1 person in common (Kevin Plummer)
- TAMPA THEATRE INC Tampa, FL · 1 person in common (Kevin Plummer)
- TAMPA DOWNTOWN PARTNERSHIP INC Tampa, FL · 1 person in common (Kevin Plummer)
- TAMPA HILLSBOROUGH ECONOMIC DEVELOPMENT CORPORATION Tampa, FL · 1 person in common (Patrick Hwu)
- GREATER TAMPA CHAMBER OF COMMERCE INC Tampa, FL · 1 person in common (Kevin Plummer)
- FRIENDS OF THE RIVERWALK INC Tampa, FL · 1 person in common (Kevin Plummer)
Funders of this organization
43 grantors reported grants to this organization, $75,673,897 in all, tax years 2009 to 2025; the 25 largest shown (all 43). Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV
| Grantor | Total given | Grants | Latest year's amount | Latest year | Years given | Type | Match | Grants |
|---|---|---|---|---|---|---|---|---|
| H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION INC | $53,314,741 | 16 | $5,880,613 | 2024 | 2009-2024 | Public charity | Exact | show |
| BLOOD CANCER UNITED INC | $6,659,898 | 9 | $1,312,498 | 2024 | 2015-2018, 2020-2024 | Public charity | Exact | show |
| AMERICAN CANCER SOCIETY INC | $4,532,785 | 6 | $10,000 | 2024 | 2014, 2022-2024 | Public charity | Exact | show |
| H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC | $3,320,448 | 14 | $435,238 | 2024 | 2011-2024 | Public charity | Exact | show |
| FRED HUTCHINSON CANCER RESEARCH CENTER | $2,033,264 | 30 | $56,883 | 2021 | 2010-2021 | Public charity | Exact | show |
| UNIVERSITY OF MIAMI | $2,010,640 | 9 | $318,276 | 2018 | 2009-2012, 2015-2018 | Public charity | Exact | show |
| JOHNS HOPKINS UNIVERSITY | $1,010,829 | 13 | $290,520 | 2024 | 2010-2012, 2015-2024 | DAF sponsor | Exact | show |
| YALE UNIVERSITY | $567,222 | 8 | $36,711 | 2023 | 2013-2015, 2019-2023 | DAF sponsor | Exact | show |
| MAYO CLINIC | $377,080 | 3 | $15,341 | 2013 | 2010-2011, 2013 | Public charity | Exact | show |
| VANDERBILT UNIVERSITY | $255,102 | 1 | $255,102 | 2013 | 2013 | Public charity | Exact | show |
| MAYO CLINIC | $157,995 | 2 | $105,050 | 2013 | 2011, 2013 | Public charity | Exact | show |
| FIDELITY INVESTMENTS CHARITABLE GIFT FUND | $141,689 | 8 | $16,285 | 2024 | 2016-2018, 2020-2024 | DAF sponsor | Exact | show |
| THE CHILDRENS HOSPITAL OF PHILADELPHIA | $119,829 | 3 | $53,470 | 2024 | 2018-2019, 2024 | Public charity | Exact | show |
| FRED HUTCHINSON CANCER CENTER | $115,640 | 3 | $64,840 | 2024 | 2021, 2023-2024 | Public charity | Exact | show |
| GATEWAY FOR CANCER RESEARCH INC | $106,244 | 1 | $106,244 | 2015 | 2015 | Public charity | Exact | show |
| METAVIVOR RESEARCH AND SUPPORT INC | $100,000 | 1 | $100,000 | 2022 | 2022 | Public charity | Exact | show |
| TEEN CANCER AMERICA INC | $100,000 | 1 | $100,000 | 2015 | 2015 | Public charity | Exact | show |
| PATIENT ACCESS NETWORK FOUNDATION | $94,624 | 4 | $45,274 | 2015 | 2010, 2013-2015 | Public charity | Exact | show |
| DONOR ADVISED CHARITABLE GIVING | $89,300 | 5 | $11,300 | 2024 | 2020-2024 | DAF sponsor | Exact | show |
| GULF COAST COMMUNITY FOUNDATION INC | $84,709 | 4 | $31,075 | 2024 | 2017, 2021, 2023-2024 | DAF sponsor | Exact | show |
| THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC | $67,500 | 2 | $30,000 | 2022 | 2021-2022 | Public charity | Exact | show |
| HEARING THE OVARIAN CANCER WHISPER INC | $62,500 | 1 | $62,500 | 2023 | 2023 | Public charity | Exact | show |
| OLD DOMINION UNIVERSITY RESEARCH FOUNDATION | $51,062 | 3 | $26,218 | 2022 | 2020-2022 | Public charity | Exact | show |
| GRAND CHAPTER OF FLORIDA ORDER OF THE EASTERN STAR CHARITABLE | $44,461 | 1 | $44,461 | 2024 | 2024 | Public charity | Exact | show |
| NMDP FOUNDATION | $36,000 | 1 | $36,000 | 2021 | 2021 | Public charity | Exact | show |
Nearby + Similar BETA
Organizations like this one: what they do and who they are linked to
Same category: NTEE code and revenue
Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. NTEE: the IRS’s code when it lists one, otherwise FURP’s inferred code. Same state only · More (100)
| Organization | State | NTEE | Latest revenue | Latest expenses | Top-paid title | Top pay | Why similar |
|---|---|---|---|---|---|---|---|
| SHRINERS HOSPITALS FOR CHILDREN | FL | E24 | $1,582,506,437 | $1,193,256,330 | CHIEF OF STAFF | $2,387,804 | Same NTEE code E24, revenue within 2x, same state |
| THE NEMOURS FOUNDATION | FL | E24 | $2,357,991,833 | $2,111,711,586 | President and CEO | $3,081,278 | Same NTEE code E24, revenue within 2x, same state |
| ST JUDE CHILDRENS RESEARCH HOSPITAL INC | TN | E24 | $2,208,853,162 | $1,897,571,834 | PRESIDENT/CEO | $1,713,883 | Same NTEE code E24, revenue within 2x |
| FRED HUTCHINSON CANCER CENTER | WA | E24 | $2,532,392,907 | $2,405,985,717 | President & Director | $2,598,413 | Same NTEE code E24, revenue within 2x |
| CHILDRENS HOSPITAL MEDICAL CENTER | OH | E24 | $3,568,680,376 | $3,363,161,573 | DIV. DIR, CARDIOLOGY | $3,370,355 | Same NTEE code E24, revenue within 2x |
| CHILDRENS HOSPITAL MEDICAL CENTER OF AKRON | OH | E24 | $1,540,288,244 | $1,353,888,762 | BOD/OFFICER-PRESIDENT AND CEO | $1,791,308 | Same NTEE code E24, revenue within 2x |
| CHILDRENS HOSPITAL LOS ANGELES | CA | E24 | $1,816,852,966 | $1,930,797,327 | Director, CEO | $1,888,151 | Same NTEE code E24, revenue within 2x |
| RADY CHILDRENS HOSPITAL SAN DIEGO | CA | E24 | $1,762,087,501 | $1,717,147,159 | PRESIDENT & CEO | $2,563,540 | Same NTEE code E24, revenue within 2x |
| TEXAS CHILDRENS HOSPITAL | TX | E24 | $4,436,955,658 | $4,105,997,047 | BOARD MEMBER, CHAIR & CEO THROUGH 10/4/24 | $13,338,019 | Same NTEE code E24, revenue within 2x |
| LUCILE SALTER PACKARD CHILDRENS HOSPITAL AT STANFORD | CA | E24 | $2,890,101,302 | $2,734,866,795 | DIRECTOR | $5,385,633 | Same NTEE code E24, revenue within 2x |
| CHILDRENS MERCY HOSPITAL | MO | E24 | $2,340,991,656 | $2,006,474,542 | Director; President & CEO; End 1/2/25 | $1,803,068 | Same NTEE code E24, revenue within 2x |
| CITY OF HOPE NATIONAL MEDICAL CENTER | CA | E24 | $3,432,349,751 | $3,288,442,084 | PRESIDENT & CEO | $7,115,860 | Same NTEE code E24, revenue within 2x |
| CHILDRENS HOSPITAL COLORADO | CO | E24 | $2,014,273,578 | $1,968,035,328 | Chief Executive Officer | $4,286,194 | Same NTEE code E24, revenue within 2x |
| SEATTLE CHILDRENS HOSPITAL | WA | E24 | $3,072,099,534 | $2,598,347,643 | FORMER OFFICER | $2,856,316 | Same NTEE code E24, revenue within 2x |
| COOK CHILDRENS MEDICAL CENTER | TX | E24 | $2,268,395,631 | $1,746,134,010 | CEO | $3,598,135 | Same NTEE code E24, revenue within 2x |
| CHILDRENS HOSPITAL CORPORATION | MA | E24 | $3,588,588,824 | $3,527,089,859 | Chief Executive Officer | $3,490,323 | Same NTEE code E24, revenue within 2x |
| CHILDRENS HOSPITAL OF ORANGE COUNTY | CA | E24 | $1,687,593,095 | $1,470,505,641 | PRESIDENT & CEO | $2,563,540 | Same NTEE code E24, revenue within 2x |
| PHOENIX CHILDRENS HOSPITAL | AZ | E24 | $1,736,932,091 | $1,538,377,122 | DIRECTOR/PRESIDENT & CEO | $3,558,771 | Same NTEE code E24, revenue within 2x |
| DRISCOLL CHILDRENS HOSPITAL | TX | E24 | $1,456,858,271 | $916,288,284 | EXECUTIVE VICE PRESIDENT & COO | $2,429,480 | Same NTEE code E24, revenue within 2x |
| NEW YORK SOCIETY FOR THE RELIEF OF RUPTURED & CRIPPLED MAINTAINING | NY | E24 | $1,756,859,714 | $1,642,543,258 | President & CEO | $5,329,588 | Same NTEE code E24, revenue within 2x |
| DUKE HEALTH INTEGRATED PRACTICE INC | NC | E24 | $1,331,731,495 | $1,483,911,564 | PHYSICIAN | $3,376,664 | Same NTEE code E24, revenue within 2x |
| ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | IL | E24 | $1,726,489,572 | $1,477,118,547 | Ex-Officio Director/President & CEO LCH | $2,617,499 | Same NTEE code E24, revenue within 2x |
| CHILDRENS HOSPITAL | DC | E24 | $1,872,813,787 | $1,777,542,451 | FORMER CHIEF OPERATING OFFICER | $3,140,501 | Same NTEE code E24, revenue within 2x |
| CHILDRENS HEALTH SYSTEM OF TEXAS | TX | E24 | $2,662,618,681 | $2,449,136,918 | President CEO | $4,345,262 | Same NTEE code E24, revenue within 2x |
| MHM SUPPORT SERVICES | MO | E24 | $1,656,435,434 | $1,714,673,169 | President, Mercy Health CEO | $8,335,401 | Same NTEE code E24, revenue within 2x |
Who funds organizations like this
Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).
The full list · all similar organizations
Where the money went
Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.
2024 · Form 990 · $2,186,992,097 spent · pay $688,267,238 · grants $19,081,912 · events $471,305
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | MEDICAL SUPPLIES | $994,865,775 | $994,865,775 | $0 | - | 45.5% |
| Other salaries and wages | $545,312,268 | $410,877,828 | $134,434,440 | - | 24.9% | |
| Office expenses | $116,891,548 | $84,903,970 | $31,987,578 | - | 5.3% | |
| Fees: other services | $76,391,253 | $57,655,806 | $18,735,447 | - | 3.5% | |
| Other employee benefits | $75,094,291 | $66,353,128 | $8,741,163 | - | 3.4% | |
| Depreciation and depletion | $67,887,693 | $15,354,610 | $52,533,083 | - | 3.1% | |
| Information technology | $46,413,784 | $211,404 | $46,202,380 | - | 2.1% | |
| All other expenses | $43,132,028 | $39,014,953 | $4,117,075 | - | 2.0% | |
| Payroll taxes | $38,392,064 | $29,157,288 | $9,234,776 | - | 1.8% | |
| Occupancy | $28,236,804 | $8,252,884 | $19,983,920 | - | 1.3% | |
| Other (as described) | BAD DEBT EXPENSES | $27,306,969 | $27,306,969 | $0 | - | 1.2% |
| Interest | $27,212,968 | - | $27,212,968 | - | 1.2% | |
| Other (as described) | HCCB ASSESSMENT | $26,907,632 | $26,907,632 | $0 | - | 1.2% |
| Pension plan contributions | $24,074,771 | $17,752,891 | $6,321,880 | - | 1.1% | |
| Grants to US organizations and governments | $19,081,912 | $19,081,912 | - | - | 0.9% | |
| Advertising and promotion | $13,407,237 | $10,713 | $13,396,524 | - | 0.6% | |
| Travel | $5,549,102 | $1,819,612 | $3,729,490 | - | 0.3% | |
| Pay: officers, directors, trustees, key employees | $5,393,844 | $5,084,238 | $309,606 | - | 0.2% | |
| Fees: legal | $2,518,978 | - | $2,518,978 | - | 0.1% | |
| Insurance | $1,856,068 | - | $1,856,068 | - | 0.1% | |
| Conferences, conventions and meetings | $471,305 | $471,305 | - | - | 0.0% | |
| Fees: lobbying | $339,972 | - | $339,972 | - | 0.0% | |
| Fees: accounting | $253,831 | - | $253,831 | - | 0.0% | |
| Other (as described) | ALLOCATION OF INTERCOMP | $0 | $120,806,903 | -$120,806,903 | - | 0.0% |
| Total | $2,186,992,097 | 100% |
2023 · Form 990 · $1,863,950,104 spent · pay $631,063,126 · grants $20,656,427 · events $182,482
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | MEDICAL SUPPLIES | $806,020,929 | $806,020,929 | $0 | - | 43.2% |
| Other salaries and wages | $504,164,678 | $377,355,234 | $126,809,444 | - | 27.0% | |
| Office expenses | $97,664,095 | $72,352,648 | $25,311,447 | - | 5.2% | |
| Fees: other services | $70,766,679 | $51,348,764 | $19,417,915 | - | 3.8% | |
| Other employee benefits | $67,157,165 | $58,889,874 | $8,267,291 | - | 3.6% | |
| Depreciation and depletion | $58,226,093 | $15,947,203 | $42,278,890 | - | 3.1% | |
| Information technology | $44,187,376 | $179,531 | $44,007,845 | - | 2.4% | |
| Payroll taxes | $35,129,321 | $26,568,024 | $8,561,297 | - | 1.9% | |
| Occupancy | $24,547,763 | $7,018,608 | $17,529,155 | - | 1.3% | |
| Other (as described) | BAD DEBT EXPENSES - PAT | $23,258,217 | $23,258,217 | $0 | - | 1.2% |
| Other (as described) | HCCB ASSESSMENT | $22,458,828 | $22,458,828 | $0 | - | 1.2% |
| Interest | $21,838,337 | - | $21,838,337 | - | 1.2% | |
| Grants to US organizations and governments | $20,656,427 | $20,656,427 | - | - | 1.1% | |
| Pension plan contributions | $19,882,077 | $14,775,546 | $5,106,531 | - | 1.1% | |
| All other expenses | $18,095,047 | $14,147,302 | $3,947,745 | - | 1.0% | |
| Advertising and promotion | $13,085,206 | $3,005 | $13,082,201 | - | 0.7% | |
| Travel | $5,543,644 | $1,645,611 | $3,898,033 | - | 0.3% | |
| Pay: officers, directors, trustees, key employees | $4,626,748 | $4,329,248 | $297,500 | - | 0.2% | |
| Fees: legal | $3,585,682 | - | $3,585,682 | - | 0.2% | |
| Insurance | $2,152,543 | - | $2,152,543 | - | 0.1% | |
| Fees: lobbying | $382,436 | - | $382,436 | - | 0.0% | |
| Fees: accounting | $235,194 | - | $235,194 | - | 0.0% | |
| Conferences, conventions and meetings | $182,482 | $182,482 | - | - | 0.0% | |
| Pay: disqualified persons | $103,137 | $96,505 | $6,632 | - | 0.0% | |
| Other (as described) | ALLOCATION OF INTERCOMP | $0 | $84,274,962 | -$84,274,962 | - | 0.0% |
| Total | $1,863,950,104 | 100% |
2022 · Form 990 · $1,622,473,343 spent · pay $533,208,793 · grants $20,660,430 · events $242,671
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | MEDICAL SUPPLIES | $728,619,301 | $728,619,301 | $0 | - | 44.9% |
| Other salaries and wages | $426,772,774 | $323,677,419 | $103,095,355 | - | 26.3% | |
| Office expenses | $82,796,361 | $60,523,189 | $22,273,172 | - | 5.1% | |
| Fees: other services | $66,126,605 | $46,518,594 | $19,608,011 | - | 4.1% | |
| Other employee benefits | $55,435,028 | $48,979,827 | $6,455,201 | - | 3.4% | |
| Information technology | $44,285,398 | $34,057 | $44,251,341 | - | 2.7% | |
| Depreciation and depletion | $39,493,387 | $15,515,863 | $23,977,524 | - | 2.4% | |
| Payroll taxes | $29,583,764 | $22,477,197 | $7,106,567 | - | 1.8% | |
| Occupancy | $21,153,259 | $5,759,371 | $15,393,888 | - | 1.3% | |
| Grants to US organizations and governments | $20,660,430 | $20,660,430 | - | - | 1.3% | |
| Other (as described) | HCCB ASSESSMENT | $20,399,214 | $20,399,214 | $0 | - | 1.3% |
| All other expenses | $19,202,461 | $10,799,897 | $8,402,564 | - | 1.2% | |
| Pension plan contributions | $17,528,718 | $13,130,612 | $4,398,106 | - | 1.1% | |
| Other (as described) | BAD DEBT EXPENSES - PAT | $16,758,134 | $16,758,134 | $0 | - | 1.0% |
| Advertising and promotion | $12,153,823 | $30,933 | $12,122,890 | - | 0.7% | |
| Interest | $7,244,742 | - | $7,244,742 | - | 0.4% | |
| Travel | $4,884,839 | $1,583,380 | $3,301,459 | - | 0.3% | |
| Pay: officers, directors, trustees, key employees | $3,888,509 | $3,634,978 | $253,531 | - | 0.2% | |
| Fees: legal | $3,074,733 | - | $3,074,733 | - | 0.2% | |
| Insurance | $1,541,461 | - | $1,541,461 | - | 0.1% | |
| Fees: lobbying | $428,983 | - | $428,983 | - | 0.0% | |
| Conferences, conventions and meetings | $242,671 | $242,671 | - | - | 0.0% | |
| Fees: accounting | $198,748 | - | $198,748 | - | 0.0% | |
| Other (as described) | ALLOCATION OF INTERCOMP | $0 | $77,777,479 | -$77,777,479 | - | 0.0% |
| Total | $1,622,473,343 | 100% |
2021 · Form 990 · $1,409,693,924 spent · pay $485,396,218 · grants $10,633,932 · events $210,745
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | MEDICAL SUPPLIES | $612,415,277 | $612,415,277 | - | - | 43.4% |
| Other salaries and wages | $390,133,492 | $300,132,971 | $90,000,521 | - | 27.7% | |
| Office expenses | $77,662,168 | $56,923,780 | $20,738,388 | - | 5.5% | |
| Fees: other services | $66,176,520 | $42,926,060 | $23,250,460 | - | 4.7% | |
| Other employee benefits | $49,825,311 | $44,494,709 | $5,330,602 | - | 3.5% | |
| Depreciation and depletion | $40,395,528 | $15,979,733 | $24,415,795 | - | 2.9% | |
| Information technology | $30,208,947 | - | $30,208,947 | - | 2.1% | |
| Payroll taxes | $25,735,684 | $19,713,801 | $6,021,883 | - | 1.8% | |
| Occupancy | $20,562,022 | $5,464,293 | $15,097,729 | - | 1.5% | |
| Other (as described) | HCCB ASSESSMENT | $17,902,022 | $17,902,022 | $0 | - | 1.3% |
| Pension plan contributions | $15,972,240 | $12,094,683 | $3,877,557 | - | 1.1% | |
| Other (as described) | BAD DEBT EXPENSES - PAT | $12,018,243 | $12,018,243 | $0 | - | 0.9% |
| All other expenses | $11,962,470 | $4,495,362 | $7,467,108 | - | 0.8% | |
| Grants to US organizations and governments | $10,633,932 | $10,633,932 | - | - | 0.8% | |
| Advertising and promotion | $10,088,219 | $12,127 | $10,076,092 | - | 0.7% | |
| Interest | $6,736,407 | - | $6,736,407 | - | 0.5% | |
| Fees: legal | $3,851,792 | - | $3,851,792 | - | 0.3% | |
| Pay: officers, directors, trustees, key employees | $3,729,491 | $3,519,521 | $209,970 | - | 0.3% | |
| Travel | $1,528,033 | $1,349,956 | $178,077 | - | 0.1% | |
| Insurance | $1,392,797 | - | $1,392,797 | - | 0.1% | |
| Fees: lobbying | $375,815 | - | $375,815 | - | 0.0% | |
| Conferences, conventions and meetings | $210,745 | $210,745 | - | - | 0.0% | |
| Fees: accounting | $176,769 | - | $176,769 | - | 0.0% | |
| Other (as described) | ALLOCATION OF INTERCOMP | $0 | $75,179,121 | -$75,179,121 | - | 0.0% |
| Total | $1,409,693,924 | 100% |
2020 · Form 990 · $1,233,194,674 spent · pay $420,000,694 · grants $10,578,432 · events $0
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | MEDICAL SUPPLIES | $520,703,932 | $520,693,422 | $10,510 | - | 42.2% |
| Other salaries and wages | $333,851,280 | $251,918,958 | $81,932,322 | - | 27.1% | |
| Office expenses | $76,637,741 | $55,669,137 | $20,968,604 | - | 6.2% | |
| Fees: other services | $60,621,162 | $29,735,249 | $30,885,913 | - | 4.9% | |
| Other employee benefits | $45,116,913 | $40,252,227 | $4,864,686 | - | 3.7% | |
| Depreciation and depletion | $39,713,090 | $15,342,996 | $24,370,094 | - | 3.2% | |
| Information technology | $28,261,877 | - | $28,261,877 | - | 2.3% | |
| Payroll taxes | $22,798,754 | $17,356,049 | $5,442,705 | - | 1.8% | |
| Occupancy | $18,891,118 | $5,639,809 | $13,251,309 | - | 1.5% | |
| Other (as described) | HCCB ASSESSMENT | $15,911,256 | $15,911,256 | - | - | 1.3% |
| Pension plan contributions | $14,207,533 | $10,739,570 | $3,467,963 | - | 1.2% | |
| Other (as described) | BAD DEBT EXPENSES - PAT | $11,867,841 | $11,867,841 | $0 | - | 1.0% |
| Grants to US organizations and governments | $10,578,432 | $10,578,432 | - | - | 0.9% | |
| All other expenses | $8,292,413 | $4,140,999 | $4,151,414 | - | 0.7% | |
| Advertising and promotion | $8,082,912 | $11,799 | $8,071,113 | - | 0.7% | |
| Interest | $7,079,554 | - | $7,079,554 | - | 0.6% | |
| Fees: legal | $4,604,646 | - | $4,604,646 | - | 0.4% | |
| Pay: officers, directors, trustees, key employees | $4,026,214 | $3,744,379 | $281,835 | - | 0.3% | |
| Insurance | $1,192,903 | - | $1,192,903 | - | 0.1% | |
| Fees: lobbying | $448,397 | - | $448,397 | - | 0.0% | |
| Fees: accounting | $222,739 | - | $222,739 | - | 0.0% | |
| Travel | $83,967 | $39,621 | $44,346 | - | 0.0% | |
| Other (as described) | ALLOCATION OF INTERCOMP | $0 | $69,904,598 | -$69,904,598 | - | 0.0% |
| Total | $1,233,194,674 | 100% |
2019 · Form 990 · $1,080,580,709 spent · pay $384,677,848 · grants $7,680,013 · events $0
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | MEDICAL SUPPLIES | $426,054,312 | $426,052,765 | $1,547 | - | 39.4% |
| Other salaries and wages | $303,997,145 | $231,132,580 | $72,864,565 | - | 28.1% | |
| Office expenses | $63,260,387 | $45,023,668 | $18,236,719 | - | 5.9% | |
| Fees: other services | $60,366,453 | $30,133,254 | $30,233,199 | - | 5.6% | |
| Other employee benefits | $43,021,297 | $37,936,763 | $5,084,534 | - | 4.0% | |
| Depreciation and depletion | $38,812,433 | $14,362,628 | $24,449,805 | - | 3.6% | |
| Information technology | $26,444,154 | - | $26,444,154 | - | 2.4% | |
| Payroll taxes | $21,108,666 | $16,265,308 | $4,843,358 | - | 2.0% | |
| Occupancy | $16,856,357 | $5,546,363 | $11,309,994 | - | 1.6% | |
| Other (as described) | BAD DEBT EXPENSE - PATI | $14,290,715 | $14,290,715 | - | - | 1.3% |
| Other (as described) | HCCB ASSESSMENT | $12,935,724 | $12,935,724 | - | - | 1.2% |
| Pension plan contributions | $12,827,473 | $9,805,635 | $3,021,838 | - | 1.2% | |
| Grants to US organizations and governments | $7,680,013 | $7,680,013 | - | - | 0.7% | |
| All other expenses | $7,571,932 | $3,905,395 | $3,666,537 | - | 0.7% | |
| Interest | $7,313,835 | - | $7,313,835 | - | 0.7% | |
| Advertising and promotion | $6,319,006 | $19,113 | $6,299,893 | - | 0.6% | |
| Fees: legal | $5,487,503 | - | $5,487,503 | - | 0.5% | |
| Pay: officers, directors, trustees, key employees | $3,723,267 | $3,462,638 | $260,629 | - | 0.3% | |
| Insurance | $1,217,250 | - | $1,217,250 | - | 0.1% | |
| Travel | $660,605 | $353,444 | $307,161 | - | 0.1% | |
| Fees: lobbying | $441,210 | - | $441,210 | - | 0.0% | |
| Fees: accounting | $190,972 | - | $190,972 | - | 0.0% | |
| Other (as described) | ALLOC OF INTERCO EXP | $0 | $68,842,029 | -$68,842,029 | - | 0.0% |
| Total | $1,080,580,709 | 100% |
2018 · Form 990 · $1,017,284,444 spent · pay $354,689,002 · grants $10,589,432 · events $366,429
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | MEDICAL SUPPLIES | $407,236,887 | $407,228,574 | $8,313 | - | 40.0% |
| Other salaries and wages | $279,539,492 | $214,328,673 | $65,210,819 | - | 27.5% | |
| Office expenses | $66,761,452 | $44,459,080 | $22,302,372 | - | 6.6% | |
| Fees: other services | $50,839,756 | $22,176,278 | $28,663,478 | - | 5.0% | |
| Other employee benefits | $39,300,718 | $34,612,055 | $4,688,663 | - | 3.9% | |
| Depreciation and depletion | $35,064,547 | $12,609,693 | $22,454,854 | - | 3.4% | |
| Information technology | $22,844,781 | - | $22,844,781 | - | 2.2% | |
| Payroll taxes | $19,544,589 | $15,188,471 | $4,356,118 | - | 1.9% | |
| Occupancy | $17,292,412 | $5,562,372 | $11,730,040 | - | 1.7% | |
| Other (as described) | HCCB ASSESSMENT | $13,026,704 | $13,026,704 | - | - | 1.3% |
| Pension plan contributions | $12,737,003 | $9,884,394 | $2,852,609 | - | 1.3% | |
| Other (as described) | BAD DEBT EXPENSE - PATI | $12,571,692 | $12,571,692 | - | - | 1.2% |
| Grants to US organizations and governments | $10,589,432 | $10,589,432 | - | - | 1.0% | |
| Interest | $7,666,005 | - | $7,666,005 | - | 0.8% | |
| All other expenses | $7,276,122 | $4,108,144 | $3,167,978 | - | 0.7% | |
| Advertising and promotion | $6,071,711 | $13,746 | $6,057,965 | - | 0.6% | |
| Pay: officers, directors, trustees, key employees | $3,439,128 | $3,191,801 | $247,327 | - | 0.3% | |
| Fees: legal | $2,456,632 | - | $2,456,632 | - | 0.2% | |
| Insurance | $1,003,156 | - | $1,003,156 | - | 0.1% | |
| Travel | $877,009 | $448,936 | $428,073 | - | 0.1% | |
| Fees: lobbying | $428,866 | - | $428,866 | - | 0.0% | |
| Conferences, conventions and meetings | $366,429 | $366,429 | - | - | 0.0% | |
| Fees: accounting | $221,849 | - | $221,849 | - | 0.0% | |
| Pay: disqualified persons | $128,072 | $118,862 | $9,210 | - | 0.0% | |
| Other (as described) | ALLOC OF INTERCO EXP | $0 | $64,571,418 | -$64,571,418 | - | 0.0% |
| Total | $1,017,284,444 | 100% |
2017 · Form 990 · $874,970,844 spent · pay $327,744,767 · grants $2,567,866 · events $443,738
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | MEDICAL SUPPLIES | $304,254,697 | $304,250,275 | $4,422 | - | 34.8% |
| Other salaries and wages | $253,863,830 | $195,952,814 | $57,911,016 | - | 29.0% | |
| Office expenses | $60,274,059 | $41,015,203 | $19,258,856 | - | 6.9% | |
| Fees: other services | $49,786,786 | $30,884,782 | $18,902,004 | - | 5.7% | |
| Other employee benefits | $39,002,581 | $34,635,364 | $4,367,217 | - | 4.5% | |
| Depreciation and depletion | $35,473,992 | $16,107,772 | $19,366,220 | - | 4.1% | |
| Information technology | $21,934,652 | - | $21,934,652 | - | 2.5% | |
| Other (as described) | BAD DEBT EXPENSE | $20,715,539 | $20,715,539 | - | - | 2.4% |
| Payroll taxes | $17,977,568 | $14,099,667 | $3,877,901 | - | 2.1% | |
| Occupancy | $16,152,639 | $5,290,203 | $10,862,436 | - | 1.8% | |
| Pension plan contributions | $12,938,711 | $10,271,664 | $2,667,047 | - | 1.5% | |
| Other (as described) | HCCB ASSESSMENT | $10,868,668 | $10,868,668 | - | - | 1.2% |
| Interest | $7,786,846 | - | $7,786,846 | - | 0.9% | |
| Advertising and promotion | $6,545,398 | $25,670 | $6,519,728 | - | 0.7% | |
| All other expenses | $4,932,253 | $2,100,906 | $2,831,347 | - | 0.6% | |
| Pay: officers, directors, trustees, key employees | $3,552,024 | $3,323,219 | $228,805 | - | 0.4% | |
| Fees: legal | $2,852,294 | - | $2,852,294 | - | 0.3% | |
| Grants to US organizations and governments | $2,567,866 | $2,567,866 | - | - | 0.3% | |
| Insurance | $1,143,737 | - | $1,143,737 | - | 0.1% | |
| Travel | $763,189 | $402,942 | $360,247 | - | 0.1% | |
| Fees: lobbying | $522,463 | - | $522,463 | - | 0.1% | |
| Conferences, conventions and meetings | $443,738 | $443,738 | - | - | 0.1% | |
| Pay: disqualified persons | $410,053 | $383,639 | $26,414 | - | 0.0% | |
| Fees: accounting | $207,261 | - | $207,261 | - | 0.0% | |
| Other (as described) | ALLOCATION OF INTERCO EXP | - | $59,964,487 | -$59,964,487 | - | 0.0% |
| Total | $874,970,844 | 100% |
2016 · Form 990 · $781,216,193 spent · pay $305,393,332 · grants $3,725,500 · events $489,099
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | MEDICAL SUPPLIES | $257,252,917 | $257,248,841 | $4,076 | - | 32.9% |
| Other salaries and wages | $235,891,306 | $181,264,411 | $54,626,895 | - | 30.2% | |
| Office expenses | $54,926,731 | $37,728,369 | $17,198,362 | - | 7.0% | |
| Fees: other services | $48,043,043 | $31,931,895 | $16,111,148 | - | 6.1% | |
| Other employee benefits | $36,312,003 | $32,321,628 | $3,990,375 | - | 4.6% | |
| Depreciation and depletion | $32,289,365 | $14,053,562 | $18,235,803 | - | 4.1% | |
| Information technology | $21,872,003 | - | $21,872,003 | - | 2.8% | |
| Payroll taxes | $16,636,322 | $12,907,415 | $3,728,907 | - | 2.1% | |
| Occupancy | $15,621,861 | $4,424,316 | $11,197,545 | - | 2.0% | |
| Pension plan contributions | $11,772,946 | $9,303,057 | $2,469,889 | - | 1.5% | |
| Other (as described) | HCCB ASSESSMENT | $9,624,504 | $9,624,504 | - | - | 1.2% |
| Interest | $8,419,185 | - | $8,419,185 | - | 1.1% | |
| Other (as described) | BAD DEBT EXPENSE | $7,283,872 | $7,283,872 | - | - | 0.9% |
| Advertising and promotion | $6,511,458 | $16,413 | $6,495,045 | - | 0.8% | |
| All other expenses | $5,353,304 | $2,197,246 | $3,156,058 | - | 0.7% | |
| Pay: officers, directors, trustees, key employees | $4,289,153 | $4,014,432 | $274,721 | - | 0.5% | |
| Grants to US organizations and governments | $3,725,500 | $3,725,500 | - | - | 0.5% | |
| Fees: legal | $2,245,598 | - | $2,245,598 | - | 0.3% | |
| Travel | $842,820 | $441,715 | $401,105 | - | 0.1% | |
| Insurance | $666,897 | - | $666,897 | - | 0.1% | |
| Fees: lobbying | $507,506 | - | $507,506 | - | 0.1% | |
| Pay: disqualified persons | $491,602 | $455,349 | $36,253 | - | 0.1% | |
| Conferences, conventions and meetings | $489,099 | $489,099 | - | - | 0.1% | |
| Fees: accounting | $147,198 | - | $147,198 | - | 0.0% | |
| Other (as described) | ALLOC OF INTERCO EXP | $0 | $52,432,733 | -$52,432,733 | - | 0.0% |
| Total | $781,216,193 | 100% |
2015 · Form 990 · $700,127,638 spent · pay $281,506,279 · grants $3,000 · events $506,149
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | MEDICAL SUPPLIES | $219,082,456 | $219,079,626 | $2,830 | - | 31.3% |
| Other salaries and wages | $218,871,732 | $170,467,562 | $48,404,170 | - | 31.3% | |
| Office expenses | $49,432,213 | $32,344,322 | $17,087,891 | - | 7.1% | |
| Other (as described) | PURCHASED SERVICES | $35,417,708 | $21,940,882 | $13,476,826 | - | 5.1% |
| Other employee benefits | $32,146,246 | $28,422,177 | $3,724,069 | - | 4.6% | |
| Depreciation and depletion | $30,591,471 | $13,133,185 | $17,458,286 | - | 4.4% | |
| Fees: other services | $19,750,206 | $13,098,503 | $6,651,703 | - | 2.8% | |
| Occupancy | $15,936,185 | $3,833,212 | $12,102,973 | - | 2.3% | |
| Payroll taxes | $15,564,346 | $12,263,734 | $3,300,612 | - | 2.2% | |
| All other expenses | $14,009,367 | $9,057,250 | $4,952,117 | - | 2.0% | |
| Pension plan contributions | $10,947,714 | $8,668,520 | $2,279,194 | - | 1.6% | |
| Interest | $9,108,972 | - | $9,108,972 | - | 1.3% | |
| Other (as described) | HCCB ASSESSMENT | $8,663,756 | $8,663,756 | - | - | 1.2% |
| Advertising and promotion | $5,833,936 | $29,519 | $5,804,417 | - | 0.8% | |
| Information technology | $5,594,027 | - | $5,594,027 | - | 0.8% | |
| Pay: officers, directors, trustees, key employees | $3,691,410 | $3,471,703 | $219,707 | - | 0.5% | |
| Fees: legal | $1,982,965 | - | $1,982,965 | - | 0.3% | |
| Insurance | $1,184,396 | - | $1,184,396 | - | 0.2% | |
| Travel | $785,226 | $369,646 | $415,580 | - | 0.1% | |
| Conferences, conventions and meetings | $506,149 | $506,149 | - | - | 0.1% | |
| Fees: lobbying | $439,816 | - | $439,816 | - | 0.1% | |
| Fees: accounting | $299,510 | - | $299,510 | - | 0.0% | |
| Pay: disqualified persons | $284,831 | $222,924 | $61,907 | - | 0.0% | |
| Grants to US organizations and governments | $3,000 | $3,000 | - | - | 0.0% | |
| Other (as described) | ALLOC OF INTERCO EXP | $0 | $55,886,901 | -$55,886,901 | - | 0.0% |
| Total | $700,127,638 | 100% |
2014 · Form 990 · $651,431,428 spent · pay $260,232,114 · grants $12,583,712 · events $536,832
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $203,764,750 | $160,111,060 | $43,653,690 | - | 31.3% | |
| Other (as described) | MEDICAL SUPPLIES | $198,363,812 | $198,363,812 | - | - | 30.5% |
| Office expenses | $44,210,168 | $29,976,559 | $14,233,609 | - | 6.8% | |
| Other (as described) | PURCHASED SERVICES | $33,867,071 | $12,827,400 | $21,039,671 | - | 5.2% |
| Other employee benefits | $28,831,326 | $25,673,498 | $3,157,828 | - | 4.4% | |
| Depreciation and depletion | $26,519,918 | $9,985,943 | $16,533,975 | - | 4.1% | |
| Fees: other services | $18,416,821 | $12,985,511 | $5,431,310 | - | 2.8% | |
| Payroll taxes | $14,476,388 | $11,513,303 | $2,963,085 | - | 2.2% | |
| Occupancy | $12,937,595 | $3,399,217 | $9,538,378 | - | 2.0% | |
| Grants to US organizations and governments | $12,583,712 | $12,583,712 | - | - | 1.9% | |
| All other expenses | $11,343,867 | $5,349,426 | $5,994,441 | - | 1.7% | |
| Information technology | $10,640,704 | - | $10,640,704 | - | 1.6% | |
| Pension plan contributions | $9,870,491 | $7,969,771 | $1,900,720 | - | 1.5% | |
| Other (as described) | HCCB ASSESSMENT | $8,087,540 | $8,087,540 | - | - | 1.2% |
| Interest | $6,916,184 | - | $6,916,184 | - | 1.1% | |
| Pay: officers, directors, trustees, key employees | $3,015,935 | $2,836,290 | $179,645 | - | 0.5% | |
| Advertising and promotion | $2,595,233 | $19,524 | $2,575,709 | - | 0.4% | |
| Fees: legal | $1,832,753 | - | $1,832,753 | - | 0.3% | |
| Insurance | $797,010 | - | $797,010 | - | 0.1% | |
| Travel | $741,203 | $355,354 | $385,849 | - | 0.1% | |
| Conferences, conventions and meetings | $536,832 | $536,832 | - | - | 0.1% | |
| Fees: lobbying | $465,795 | - | $465,795 | - | 0.1% | |
| Fees: accounting | $343,096 | - | $343,096 | - | 0.1% | |
| Pay: disqualified persons | $273,224 | $220,205 | $53,019 | - | 0.0% | |
| Other (as described) | ALLOC OF INTERCO EXP | $0 | $48,077,903 | -$48,077,903 | - | 0.0% |
| Total | $651,431,428 | 100% |
2013 · Form 990 · $606,351,225 spent · pay $237,883,430 · grants $10,629,829 · events $481,014
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $187,770,339 | $149,012,096 | $38,758,243 | - | 31.0% | |
| Other (as described) | MEDICAL SUPPLIES | $176,792,477 | $176,781,201 | $11,276 | - | 29.2% |
| Office expenses | $44,321,281 | $29,594,812 | $14,726,469 | - | 7.3% | |
| Other (as described) | PURCHASED SERVICES | $31,925,032 | $13,166,883 | $18,758,149 | - | 5.3% |
| Depreciation and depletion | $30,049,422 | $9,870,044 | $20,179,378 | - | 5.0% | |
| Other employee benefits | $25,206,211 | $22,774,625 | $2,431,586 | - | 4.2% | |
| Fees: other services | $18,517,799 | $12,514,095 | $6,003,704 | - | 3.1% | |
| All other expenses | $13,541,194 | $10,008,357 | $3,532,837 | - | 2.2% | |
| Payroll taxes | $13,467,147 | $10,826,025 | $2,641,122 | - | 2.2% | |
| Occupancy | $11,928,333 | $3,052,305 | $8,876,028 | - | 2.0% | |
| Grants to US organizations and governments | $10,629,829 | $10,629,829 | - | - | 1.8% | |
| Pension plan contributions | $8,246,532 | $6,700,269 | $1,546,263 | - | 1.4% | |
| Information technology | $7,999,064 | - | $7,999,064 | - | 1.3% | |
| Other (as described) | HCCB ASSESSMENT | $7,888,054 | $7,888,054 | - | - | 1.3% |
| Interest | $7,030,886 | - | $7,030,886 | - | 1.2% | |
| Pay: officers, directors, trustees, key employees | $2,976,561 | $2,831,626 | $144,935 | - | 0.5% | |
| Advertising and promotion | $2,426,353 | $42,279 | $2,384,074 | - | 0.4% | |
| Fees: legal | $2,161,812 | - | $2,161,812 | - | 0.4% | |
| Insurance | $1,512,844 | - | $1,512,844 | - | 0.2% | |
| Travel | $569,060 | $262,234 | $306,826 | - | 0.1% | |
| Conferences, conventions and meetings | $481,014 | $481,014 | - | - | 0.1% | |
| Fees: lobbying | $354,552 | - | $354,552 | - | 0.1% | |
| Fees: accounting | $338,789 | - | $338,789 | - | 0.1% | |
| Pay: disqualified persons | $216,640 | $206,091 | $10,549 | - | 0.0% | |
| Other (as described) | ALLOC OF INTERCO EXP | $0 | $52,986,504 | -$52,986,504 | - | 0.0% |
| Total | $606,351,225 | 100% |
2012 · Form 990 · $564,442,968 spent · pay $220,677,758 · grants $10,597,568 · events $596,089
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $173,909,798 | $138,099,359 | $35,810,439 | - | 30.8% | |
| Other (as described) | MEDICAL SUPPLIES | $162,133,770 | $162,133,770 | - | - | 28.7% |
| Office expenses | $42,323,920 | $28,868,436 | $13,455,484 | - | 7.5% | |
| Depreciation and depletion | $30,694,687 | $10,615,342 | $20,079,345 | - | 5.4% | |
| Other (as described) | PURCHASED SERVICES | $25,987,664 | $8,727,939 | $17,259,725 | - | 4.6% |
| Other employee benefits | $22,180,269 | $19,811,104 | $2,369,165 | - | 3.9% | |
| Fees: other services | $15,758,464 | $12,027,432 | $3,731,032 | - | 2.8% | |
| Payroll taxes | $12,841,692 | $10,092,977 | $2,748,715 | - | 2.3% | |
| All other expenses | $12,306,730 | $10,226,180 | $2,080,550 | - | 2.2% | |
| Occupancy | $11,716,091 | $2,587,881 | $9,128,210 | - | 2.1% | |
| Other (as described) | BAD DEBT EXPENSE | $11,240,478 | $11,240,478 | - | - | 2.0% |
| Grants to US organizations and governments | $10,597,568 | $10,597,568 | - | - | 1.9% | |
| Pension plan contributions | $8,739,109 | $7,103,620 | $1,635,489 | - | 1.5% | |
| Interest | $7,494,856 | - | $7,494,856 | - | 1.3% | |
| Information technology | $6,648,911 | - | $6,648,911 | - | 1.2% | |
| Pay: officers, directors, trustees, key employees | $2,760,064 | $2,622,429 | $137,635 | - | 0.5% | |
| Advertising and promotion | $2,407,235 | $39,261 | $2,367,974 | - | 0.4% | |
| Fees: legal | $1,846,202 | - | $1,846,202 | - | 0.3% | |
| Insurance | $743,701 | - | $743,701 | - | 0.1% | |
| Conferences, conventions and meetings | $596,089 | $596,089 | - | - | 0.1% | |
| Travel | $548,804 | $242,023 | $306,781 | - | 0.1% | |
| Fees: lobbying | $405,925 | - | $405,925 | - | 0.1% | |
| Fees: accounting | $314,115 | - | $314,115 | - | 0.1% | |
| Pay: disqualified persons | $246,826 | $234,518 | $12,308 | - | 0.0% | |
| Other (as described) | ALLOC OF INTERCO EXP | $0 | $52,195,945 | -$52,195,945 | - | 0.0% |
| Total | $564,442,968 | 100% |
2011 · Form 990 · $562,502,915 spent · pay $222,821,589 · grants $9,341,648 · events $596,089
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $170,646,727 | $136,732,009 | $33,914,718 | - | 30.3% | |
| Other (as described) | MEDICAL SUPPLIES | $164,231,863 | $164,216,841 | $15,022 | - | 29.2% |
| Office expenses | $39,634,091 | $27,548,780 | $12,085,311 | - | 7.0% | |
| Depreciation and depletion | $32,478,579 | $12,979,502 | $19,499,077 | - | 5.8% | |
| Other employee benefits | $25,343,035 | $22,731,873 | $2,611,162 | - | 4.5% | |
| Other (as described) | PURCHASED SERVICES | $21,058,222 | $10,550,750 | $10,507,472 | - | 3.7% |
| Fees: other services | $14,178,845 | $11,152,187 | $3,026,658 | - | 2.5% | |
| Other (as described) | BAD DEBT EXPENSE | $13,297,804 | $13,297,804 | - | - | 2.4% |
| Occupancy | $12,731,832 | $3,803,821 | $8,928,011 | - | 2.3% | |
| Payroll taxes | $12,680,480 | $10,043,570 | $2,636,910 | - | 2.3% | |
| All other expenses | $11,688,721 | $9,683,240 | $2,005,481 | - | 2.1% | |
| Pension plan contributions | $10,498,458 | $8,597,171 | $1,901,287 | - | 1.9% | |
| Grants to US organizations and governments | $9,341,648 | $9,341,648 | - | - | 1.7% | |
| Interest | $7,964,098 | - | $7,964,098 | - | 1.4% | |
| Information technology | $6,830,399 | - | $6,830,399 | - | 1.2% | |
| Pay: officers, directors, trustees, key employees | $2,855,687 | $2,725,127 | $130,560 | - | 0.5% | |
| Advertising and promotion | $2,308,659 | $86,274 | $2,222,385 | - | 0.4% | |
| Fees: legal | $1,573,443 | - | $1,573,443 | - | 0.3% | |
| Pay: disqualified persons | $797,202 | $760,755 | $36,447 | - | 0.1% | |
| Insurance | $730,442 | - | $730,442 | - | 0.1% | |
| Conferences, conventions and meetings | $596,089 | $596,089 | - | - | 0.1% | |
| Travel | $527,887 | $249,242 | $278,645 | - | 0.1% | |
| Fees: lobbying | $340,484 | - | $340,484 | - | 0.1% | |
| Fees: accounting | $168,220 | - | $168,220 | - | 0.0% | |
| Other (as described) | ALLOC OF INTERCO EXP | $0 | $51,172,612 | -$51,172,612 | - | 0.0% |
| Total | $562,502,915 | 100% |
2010 · Form 990 · $509,664,148 spent · pay $173,558,237 · grants $0 · events $713,527
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Office expenses | $172,953,377 | $171,857,727 | $1,095,650 | - | 33.9% | |
| Other salaries and wages | $133,995,080 | $127,433,153 | $6,561,927 | - | 26.3% | |
| Other (as described) | INTERCOMPANY SERVICES | $82,464,333 | $33,258,403 | $49,205,930 | - | 16.2% |
| Other (as described) | PURCHASED SERVICES | $21,983,735 | $21,352,707 | $631,028 | - | 4.3% |
| Other employee benefits | $17,892,320 | $17,016,108 | $876,212 | - | 3.5% | |
| Depreciation and depletion | $11,785,762 | $11,489,079 | $296,683 | - | 2.3% | |
| Other (as described) | BAD DEBT EXPENSE | $11,357,223 | $11,357,223 | - | - | 2.2% |
| Information technology | $10,643,253 | - | $10,643,253 | - | 2.1% | |
| Payroll taxes | $10,255,837 | $9,753,594 | $502,243 | - | 2.0% | |
| Fees: other services | $9,422,431 | $8,001,294 | $1,421,137 | - | 1.8% | |
| Pension plan contributions | $8,127,873 | $7,729,840 | $398,033 | - | 1.6% | |
| Other (as described) | HCCB ASSESSMENT | $5,291,978 | $5,291,978 | - | - | 1.0% |
| Occupancy | $4,530,483 | $4,416,437 | $114,046 | - | 0.9% | |
| Pay: officers, directors, trustees, key employees | $3,056,621 | $2,906,934 | $149,687 | - | 0.6% | |
| All other expenses | $2,078,043 | $1,436,596 | $641,447 | - | 0.4% | |
| Other (as described) | CAFETERIA FOOD SERVICES | $1,710,694 | $1,710,694 | - | - | 0.3% |
| Conferences, conventions and meetings | $713,527 | $713,527 | - | - | 0.1% | |
| Fees: lobbying | $578,518 | $578,518 | - | - | 0.1% | |
| Travel | $322,303 | $251,893 | $70,410 | - | 0.1% | |
| Pay: disqualified persons | $230,506 | $219,218 | $11,288 | - | 0.0% | |
| Fees: legal | $172,575 | - | $172,575 | - | 0.0% | |
| Advertising and promotion | $97,676 | $97,676 | - | - | 0.0% | |
| Total | $509,664,148 | 100% |
2009 · Form 990 · $460,246,141 spent · pay $189,234,730 · grants $141,450 · events $602,683
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Office expenses | $157,873,799 | $153,806,608 | $4,067,191 | - | 34.3% | |
| Other salaries and wages | $148,829,396 | $118,784,652 | $30,044,744 | - | 32.3% | |
| Depreciation and depletion | $26,508,501 | $18,353,782 | $8,154,719 | - | 5.8% | |
| Other (as described) | PURCHASED SERVICES | $25,471,092 | $20,714,811 | $4,756,281 | - | 5.5% |
| Other employee benefits | $18,928,873 | $15,214,809 | $3,714,064 | - | 4.1% | |
| Occupancy | $14,191,276 | $9,825,663 | $4,365,613 | - | 3.1% | |
| Payroll taxes | $11,271,115 | $8,996,015 | $2,275,100 | - | 2.4% | |
| Fees: other services | $10,278,592 | $9,111,059 | $1,167,533 | - | 2.2% | |
| Pension plan contributions | $8,479,315 | $6,767,746 | $1,711,569 | - | 1.8% | |
| Other (as described) | BAD DEBT EXPENSE | $7,802,815 | $7,802,815 | - | - | 1.7% |
| Interest | $7,201,618 | $7,196,856 | $4,762 | - | 1.6% | |
| Information technology | $5,509,185 | - | $5,509,185 | - | 1.2% | |
| Other (as described) | HCCB ASSESSMENT | $5,500,022 | $5,500,022 | - | - | 1.2% |
| All other expenses | $2,466,604 | $1,597,491 | $869,113 | - | 0.5% | |
| Advertising and promotion | $1,959,990 | $1,959,990 | - | - | 0.4% | |
| Pay: officers, directors, trustees, key employees | $1,726,031 | $1,380,825 | $345,206 | - | 0.4% | |
| Other (as described) | CATERING/FOOD SERVICE | $1,527,854 | $1,509,683 | $18,171 | - | 0.3% |
| Other (as described) | MINOR EQUIPMENT | $1,362,921 | $506,044 | $856,877 | - | 0.3% |
| Insurance | $1,210,618 | $1,210,618 | - | - | 0.3% | |
| Fees: lobbying | $677,192 | - | $677,192 | - | 0.1% | |
| Conferences, conventions and meetings | $602,683 | $602,683 | - | - | 0.1% | |
| Travel | $357,627 | $253,481 | $104,146 | - | 0.1% | |
| Fees: accounting | $196,418 | - | $196,418 | - | 0.0% | |
| Grants to US organizations and governments | $141,450 | $141,450 | - | - | 0.0% | |
| Fees: legal | $90,172 | - | $90,172 | - | 0.0% | |
| Fees: investment management | $80,982 | - | $80,982 | - | 0.0% | |
| Total | $460,246,141 | 100% |
Federal lobbying
Lobbying Disclosure Act reports naming a client or registrant with this organization's name and state. Spent: what lobbying for it cost (firm income plus its own reported expenses). Earned: income it reported as a lobbying firm.
| Year | Spent | Earned | Reports |
|---|---|---|---|
| 2023 | $180,000 | 4 | |
| 2022 | $200,000 | 4 | |
| 2021 | $240,000 | 6 | |
| 2020 | $240,000 | 8 | |
| 2019 | $320,000 | 8 | |
| 2018 | $320,000 | 8 | |
| 2017 | $370,000 | 10 | |
| 2016 | $340,000 | 11 | |
| 2015 | $310,000 | 9 | |
| 2014 | $180,000 | 4 | |
| 2013 | $120,000 | 4 | |
| 2012 | $120,000 | 4 | |
| 2011 | $120,000 | 4 | |
| 2010 | $100,000 | 4 | |
| 2009 | $100,000 | 5 |
Issues: Budget/Appropriations, Health Issues, Defense, Medicare/Medicaid, Veterans, Medical/Disease Research/Clinical Labs
Firms hired: HOLLAND & KNIGHT LLP, VAN SCOYOC ASSOCIATES, RASKY PARTNERS, INC.
Federal grants and contracts
Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.
| Fiscal year | Grants and other assistance | Contracts | Awards |
|---|---|---|---|
| 2027 | $0 | $0 | 1 |
| 2026 | $58,793,661 | $82,034 | 154 |
| 2025 | $80,687,130 | -$39,422 | 161 |
| 2024 | $62,204,148 | $1,030,318 | 176 |
| 2023 | $75,053,314 | $1,407 | 170 |
| 2022 | $70,347,206 | $2,325,934 | 157 |
| 2021 | $48,256,806 | $113,103 | 128 |
| 2020 | $39,090,345 | $4,612,018 | 120 |
| 2019 | $42,147,400 | $1,829,102 | 114 |
| 2018 | $34,639,814 | $4,313,215 | 97 |
| 2017 | $30,212,888 | -$339,975 | 90 |
| 2016 | $42,708,968 | $2,263,503 | 82 |
| 2015 | $31,219,877 | $1,519,204 | 83 |
| 2014 | $29,209,504 | $1,066,365 | 77 |
| 2013 | $31,070,826 | $367,560 | 71 |
| 2012 | $38,386,342 | $775,834 | 89 |
| 2011 | $41,022,095 | $1,408,333 | 91 |
| 2010 | $55,156,726 | $1,325,318 | 97 |
| 2009 | $47,291,077 | $1,728,924 | 96 |
| 2008 | $80,999,793 | $530,486 | 57 |
| 2007 | $24,102,601 | $55,151 | 72 |
Largest awards · 200 shown
| Year | Agency | Kind | Program | Description | Obligated |
|---|---|---|---|---|---|
| 2026 | National Institute of Standards and Technology | Grant or other assistance | CONGRESSIONALLY-IDENTIFIED PROJECTS 11.617 | PURPOSE:THE PURPOSE OF THIS GRANT IS TO ESTABLISH A CRYOGENIC TRANSMISSION ELECTRON MICROSCOPY (CRYOTEM) FACILITY AT THE MOFFITT CANCER CENTER IN TAMPA, FL. THE | $4,200,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | MOFFITT CANCER CENTER SUPPORT GRANT | $4,054,822 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | TARGETING AGE-DRIVEN METASTATIC VULNERABILITIES IN TRIPLE-NEGATIVE BREAST CANCER | $2,100,216 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | SURVIVORSHIP IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY - PROJECT SUMMARY/ABSTRACT MULTIPLE MYELOMA IS THE SECOND M | $2,068,249 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | A HYBRID EFFECTIVENESS-IMPLEMENTATION TRIAL TO INTEGRATE PRECISION SKIN CANCER RISK FEEDBACK IN FEDERALLY QUALIFIED HEALTH CENTERS - ABSTRACT THE INCIDENCE OF S | $2,037,289 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | IMPACT OF TARGETED THERAPY ON CANCER-RELATED COGNITIVE IMPAIRMENT - PROJECT SUMMARY/ABSTRACT CANCER-RELATED COGNITIVE IMPAIRMENT (CRCI) IS COMMON AND DISTRESSIN | $1,988,242 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | EPIGENETIC AND METABOLIC BOTTLENECKS OF TUMORIGENESIS - RECURRENT METASTASIS IS THE LEADING CAUSE OF BREAST CANCER MORTALITY. DORMANCY IS A CRITICAL, BUT POORLY | $1,866,592 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | MYC-ALARMIN AXIS AS A NOVEL THERAPEUTIC VULNERABILITY IN MYELOFIBROSIS - PROJECT SUMMARY MYELOFIBROSIS (MF) IS A HEMATOLOGIC MALIGNANCY THAT IS CHARACTERIZED BY | $1,659,122 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | THE DELTA ECOLOGY OF NSCLC TREATMENT - SUMMARY – MOFFITT CSBC PROPOSAL OVERVIEW THE MOFFITT CSBC PROPOSAL IS FOCUSED ON THE ESSENTIAL AND HIGHLY DYNAMICAL INTE | $1,538,725 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | INTERROGATING THE RELATIONSHIP BETWEEN TRANSLATIONAL DYNAMICS AND NON-CANONICAL ANTIGEN PRESENTATION IN LUNG CANCER - ABSTRACT ANTIGEN PRESENTATION IS A FUNDAME | $1,448,091 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | IDENTIFICATION AND EVALUATION OF IMMUNE AND TARGETED THERAPIES FOR ACRAL MELANOMA | $1,435,737 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | MOFFITT IMAGING BIOMARKER VALIDATION CENTER | $1,322,710 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | PONCE SCHOOL OF MEDICINE-MOFFITT CANCER CENTER PARTNERSHIP (2/2) | $1,272,609 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | DEVELOPING A CANCER GALAXY COMPUTATIONAL WORKBENCH TO MEET EMERGING CANCER DATA ANALYSIS NEEDS - PROJECT SUMMARY COMPUTATIONAL ANALYSES HAVE BECOME INSTRUMENTAL | $1,226,345 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | PROJECT TITLE: TRANSFORM AND OPTIMIZE PENILE CANCER PHARMACOTHERAPY IDENTIFICATION COHORT: THE TOP-PIC STUDY | $1,119,048 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | NEUROCOGNITIVE AND PATIENT-REPORTED OUTCOMES AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY: A CONTROLLED COMPARISON - PROJECT SUMMARY THERE IS WIDESPREAD EXCIT | $1,044,728 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | PARTNERSHIP TO ASSESS VIRAL AND IMMUNE LANDSCAPE INTERSECTIONS WITH ONCOLOGY FOR PEOPLE LIVING WITH HIV (PAVILION) - PROJECT SUMMARY – OVERALL THE PARTNERSHIP C | $1,003,155 |
| 2026 | National Institutes of Health | Grant or other assistance | MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH 93.307 | INTEGRATING MOLECULAR AND SOCIAL EXPOSURES TO UNDERSTAND ACCELERATED AGING IN CANCER PATIENTS WITH HIV IN THE SOUTHEASTERN US - MODIFIED PROJECT SUMMARY/ABSTRAC | $811,939 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | HARNESSING BIG DATA TO UNDERSTAND THE CONFLUENCE OF HIV AND CANCER STIGMA IN THE US SOUTHEAST - IN THE US, DIFFERENCES IN CANCER CARE QUALITY IMPACTING PEOPLE W | $802,252 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | BODY COMPOSITION AND ADIPOSITY-ASSOCIATED THROMBOINFLAMMATION IN COLORECTAL CANCER PROGNOSIS - SUMMARY OBESITY INCREASES THE RISK OF NUMEROUS CANCERS INCLUDING | $764,357 |
| 2026 | National Institute of Standards and Technology | Grant or other assistance | CONGRESSIONALLY-IDENTIFIED PROJECTS 11.617 | PURPOSE: THE PURPOSE OF THIS GRANT IS TO DESIGN, BUILD, AND VALIDATE TWO SUB-DIFFRACTION QUANTUM-INSPIRED IMAGING DEVICE (SQUIID)-ENABLED MICROSCOPES TO ADDRESS | $750,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | POSTOPERATIVE COGNITIVE DYSFUNCTION FOLLOWING MAJOR CANCER SURGERY: A NEW APPROACH TO UNDERSTANDING CANCER-ASSOCIATED COGNITIVE DECLINE - PROJECT SUMMARY POSTOP | $726,563 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | ULTRASENSITIVE DETECTION OF CIRCULATING DNA METHYLATION FOR HEAD AND NECK CANCER PROGNOSIS - PROJECT SUMMARY/ ABSTRACT HEAD AND NECK SQUAMOUS CELL CARCINOMA (HN | $712,674 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | BIOMARKER APPROACH TO SCREENING FOR THE EARLY DETECTION OF HPV-RELATED OROPHARYNGEAL CANCER (BASH OPC) - ABSTRACT OROPHARYNGEAL CANCER (OPC) INCIDENCE IS SIGNIF | $707,563 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | UNRAVELING AGE-INDUCED MECHANISMS OF THERAPEUTIC RESISTANCE IN CANCER - PROJECT SUMMARY LUNG CANCER ACCOUNTS FOR THE LARGEST NUMBER OF CANCER-ASSOCIATED DEATHS | $707,102 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | THE MIND-BC STUDY: MIND DIET FOR BREAST CANCER COGNITION - PROJECT SUMMARY CANCER-RELATED COGNITIVE IMPAIRMENT (CRCI) IS REPORTED BY UP TO 75% OF BREAST CANCER | $696,013 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TARGETING BRANCHED-CHAIN KETO ACID ACCUMULATION IN MELANOMA LEPTOMENINGEAL DISEASE - ABSTRACT THE PROPOSED WORK AIMS TO IMPROVE OUR UNDERSTANDING AND CLINICAL M | $694,309 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CYSTEINE ACQUISITION AND UTILIZATION IN LUNG ADENOCARCINOMA - PROJECT SUMMARY CYSTEINE-DERIVED MOLECULES ARE CRUCIAL FOR CANCER CELL SURVIVAL AND PROLIFERATION | $687,593 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CHARACTERIZING THE SPOP-BRAF-MTORC1 SIGNALING AXIS IN MELANOMA PATHOGENESIS - ABSTRACT BRAF-TARGETED THERAPY HAS ACHIEVED GREAT SUCCESS IN CLINICS FOR THE TREAT | $682,495 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | SELECTIVE TARGETING OF TAF1 FUNCTION IN ACUTE MYELOID LEUKEMIA - PROJECT SUMMARY ALTHOUGH DYSREGULATED GENE TRANSCRIPTION IS A MAJOR CONTRIBUTING FACTOR IN CANC | $678,369 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | IDENTIFYING CELL SURFACE TARGETS FOR INNOVATIVE IMMUNOTHERAPY OF MULTIPLE MYELOMA - PROJECT SUMMARY MULTIPLE MYELOMA (MM) IS AN INCURABLE MALIGNANCY OF MATURE P | $669,302 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | DISRUPTING THE PROSTATE TUMOR MICROENVIRONMENT IN AFRICAN AMERICAN MEN TO PROMOTE RESPONSE TO IMMUNO-MODULATORY THERAPY - PROJECT SUMMARY AFRICAN-AMERICAN MEN ( | $668,909 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | METHYLOMIC BASIS OF SURVIVAL DISPARITIES AMONG BLACK AND WHITE WOMEN WITH HIGH-GRADE SEROUS OVARIAN CANCER - ABSTRACT EPITHELIAL OVARIAN CANCER IS THE DEADLIEST | $657,159 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | REMODELING THE IMMUNE LANDSCAPE IN BREAST CANCER LEPTOMENINGEAL DISEASE USING DENDRITIC CELL THERAPY IS AN EFFECTIVE TREATMENT AND PROTECTS AGAINST DISEASE RECU | $657,121 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | AGING, DNA METHYLATION, AND INCIDENT CARDIOVASCULAR DISEASE IN BREAST CANCER SURVIVORS - PROJECT SUMMARY/ABSTRACT THERE ARE NEARLY FOUR MILLION BREAST CANCER SU | $655,534 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | AN INTEGRATED MATHEMATICAL MODELING APPROACH TO DEFINE HOW THE AGING BONE ECOSYSTEM DRIVES MULTIPLE MYELOMA EVOLUTION AND TREATMENT RESPONSE - PROJECT SUMMARY S | $622,619 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | TARGETING MALIGNANT REPROGRAMMING OF GLIOBLASTOMA STEM CELLS THROUGH DUAL INHIBITION OF S6K1 AND BIRC3 - GLIOBLASTOMA (GBM) IS HIGHLY RESISTANT AND UNIFORMLY FA | $621,135 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | ORAL HPV RESEARCH AMONG LATIN AMERICANS LIVING WITH HIV (ORAL - H? STUDY) - ABSTRACT OROPHARYNGEAL CANCER (OPC) IS PREDOMINANTLY CAUSED BY HPV 16 AND OTHER ONCO | $607,675 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | DEFINING THE ROLE OF MAFG IN MELANOCYTE TRANSFORMATION AND MELANOMA DEVELOPMENT - PROJECT SUMMARY OVER THE PAST DECADE, NON-GENETIC MECHANISMS HAVE EMERGED AS P | $607,249 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | OPTIMIZING GAMMA/DELTA CAR-T-CELL THERAPY FOR BONE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER - PROJECT SUMMARY/ABSTRACT METASTATIC CASTRATE RESISTANT PROS | $589,581 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | RELEASE OF INTERLEUKIN-1A AS A MEDIATOR OF IMMUNE EVASION IN CANCER - PROJECT SUMMARY CELL DEATH IS THE PRIMARY GOAL OF MOST CANCER THERAPIES, BUT HOW DIFFERENT | $568,538 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | ILLUMINATING NOTCH RECEPTOR-LIGAND SELECTIVITY THROUGH STRUCTURE-GUIDED PROTEIN ENGINEERING | $552,597 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | ENDING TOBACCO USE THROUGH INTERACTIVE TAILORED MESSAGING FOR CAMBODIAN PEOPLE LIVING WITH HIV/AIDS (ENDIT) - PROJECT SUMMARY ALTHOUGH THE PREVALENCE OF TOBACCO | $552,554 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | THE ROLE OF MICROBIOTA AND MICROBIAL EXTRACELLULAR VESICLES IN METASTATIC DORMANCY IN MELANOMA MODIFICATION P00001 INCORPORATES ENTITY CHANGE TO H. LEE MOFFITT | $550,231 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | STRUCTURE-FUNCTION STUDIES OF LAG3 INTERACTIONS WITH ANTIBODIES AND CELLULAR LIGANDS - PROJECT ABSTRACT IN THIS PROPOSAL, WE WILL DETERMINE HOW ANTIBODIES AND C | $549,962 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | PROGRAM CONTROL OF CD8+ T CELL RESPONSE TO TUMORS AND TUMOR MEMORY - ABSTRACT CD8+ TUMOR INFILTRATING LYMPHOCYTES (TILS) ARE NOT ONLY CRITICAL FOR THE ANTI-TUMO | $549,460 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | ROLE OF ULK3 IN SENSITIVE AND REFRACTORY MULTIPLE MYELOMA - SUMMARY MULTIPLE MYELOMA (MM) IS AN INCURABLE AND FATAL DISEASE. REAGENTS SUCH AS THE PROTEASOME INH | $534,381 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CHARACTERIZING CYTOTOXIC THERAPY INDUCED SHIFTS IN THE COST-TO-BENEFIT RATIO OF HIGH PLOIDY - SUMMARY TRADITIONAL PHASE I DOSE-FINDING STRATEGIES MONITOR DRUG R | $520,099 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | THE IMPACT OF INFLAMMATION ON HSPC COMPOSITION AND DISEASE PROGRESSION IN CHRONIC MYELOMONOCYTIC LEUKEMIA - PROJECT SUMMARY: CHRONIC MYELOMONOCYTIC LEUKEMIA (CM | $495,033 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DEFINING AND TARGETING EPIGENETIC PLASTICITY-DRIVEN DRUG RESISTANCE AND IMMUNE ESCAPE IN MELANOMA - PROJECT SUMMARY MELANOMA IS A HETEROGENEOUS TUMOR, WITH A HI | $481,119 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | DECIPHERING THE CONTRIBUTION OF THE AGED ALVEOLAR NICHE TO LUNG CANCER EVOLUTION - PROJECT SUMMARY DESPITE AGING BEING A MAJOR RISK FACTOR FOR LUNG CANCER INCID | $463,375 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DEFINING IMPACT OF IN SITU ACTIVATION OF CD40 AND TYPE 1 INTERFERON SIGNALING ON THETME AND SYSTEMIC T CELL IMMUNITY IN MURINE MODELS AND CANCER PATIENTS - PROJ | $460,204 |
| 2026 | National Science Foundation | Grant or other assistance | MATHEMATICAL AND PHYSICAL SCIENCES 47.049 | DEVELOPMENT OF DIAZIRINE-BASED AMINATION REACTIONS -DR. JUSTIN LOPCHUK OF H. LEE MOFFITT CANCER CENTER WILL DEVELOP A SERIES OF NEW CHEMICAL METHODS AND REAGENT | $450,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | ANTI-TUMOR POTENTIAL OF TEMPERATURE-SENSITIVE P53 MUTANTS - THE P53 TUMOR SUPPRESSOR IS FREQUENTLY INACTIVATED BY MUTATIONS IN CANCER. MOST P53 POINT MUTATIONS | $444,589 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | RBFOX2 DEREGULATION PROMOTES PANCREATIC CANCER PROGRESSION THROUGH ALTERNATIVE SPLICING - SUMMARY SPLICING IS A CRITICAL BIOLOGICAL PROCESS IN CANCER INITIATION | $441,529 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | FRAGMENT-BASED TARGETING OF EMT-MEDIATED RESISTANCE IN EGFR-MUTANT LUNG CANCER - PROJECT ABSTRACT TARGETED THERAPY PROVIDES SIGNIFICANT CLINICAL BENEFIT TO PATI | $433,256 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | KETOGENIC METABOLIC THERAPY AS THERAPEUTIC ADJUNCT IN PATIENTS UNDERGOING IMMUNE CHECKPOINT INHIBITION THERAPY FOR NON-SMALL CELL LUNG CANCER - ABSTRACT IMMUNE | $432,473 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DISSECTING ENHANCER FUNCTION THROUGH INTEGRATIVE GENOMICS - PROJECT SUMMARY ENHANCERS ARE NON-CODING REGULATORY ELEMENTS THAT DIRECTLY INVOLVED IN MODULATING CE | $421,250 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | REGULATION OF SELENIUM METABOLISM AND SELENOPROTEIN SYNTHESIS - PROJECT SUMMARY SELENIUM IS AN ESSENTIAL MICRONUTRIENT THAT FUNCTIONS THROUGH ITS INCORPORATION | $421,250 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | BEHAVIORAL ONCOLOGY EDUCATION & CAREER DEVELOPMENT | $402,837 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | TARGETING AGE-DRIVEN METASTATIC VULNERABILITIES IN TRIPLE-NEGATIVE BREAST CANCER | $397,788 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CHARACTERIZING ONCOGENIC FUNCTION OF ITCH IN MELANOMA - ABSTRACT THE ITCH UBIQUITIN E3 LIGASE HAS BEEN WELL CHARACTERIZED AS A KEY MOLECULE IN IMMUNE CELLS. THE | $357,913 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | MECHANISMS OF P53 ACTIVATION DURING STRESS RESPONSE | $338,330 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | LIBRE DEL CIGARRILLO: DEVELOPMENT OF AN MHEALTH SMOKING CESSATION APP TO EXTEND REACH OF A VALIDATED SMOKING CESSATION INTERVENTION FOR SPANISH-SPEAKING SMOKER | $312,790 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DEVELOPING CHEMICAL PROBES FOR ONCOGENIC SIGNALING PATHWAYS | $293,933 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | COMMUNITY-ENGAGED DESIGN AND EVALUATION OF AN MHEALTH APP TO ADDRESS MALNUTRITION AMONG INDIVIDUALS WITH PANCREATIC CANCER | $293,412 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | GHANA INTEGRATIVE APPROACH TO CANCER RESEARCH TRAINING: THE GRACE PROGRAM - PROJECT SUMMARY/ABSTRACT CANCER INCIDENCE IS SIGNIFICANTLY INCREASING IN MANY SUB-SA | $262,176 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | ADVANCING CLINICAL TRIALS: WORKING THROUGH OUTREACH, NAVIGATION AND DIGITAL ENABLED REFERRAL AND RECRUITMENT STRATEGIES (ACT WONDERS) - ABSTRACT LIMITED PARTICI | $246,517 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | A MULTIMODAL LIQUID BIOPSY ASSAY TO QUANTIFY ANDROGEN RECEPTOR’S SOMATIC ALTERATIONS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER. - PROJECT SUMMARY THE H | $225,511 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CORE CLINICAL CENTERS FOR THE BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK (UG1) | $214,179 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | THE ROLE OF ORAL MICROBIOTA IN METASTATIC BRAIN TUMORS - PROJECT SUMMARY BRAIN METASTASIS IS A MAJOR CLINICAL CHALLENGE ASSOCIATED WITH HIGH MORBIDITY AND MORT | $175,876 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | TUMOR CELL-INTRINSIC STING SIGNALING ROLE IN SPONTANEOUS AND THERAPEUTIC INDUCTION OF TERTIARY LYMPHOID STRUCTURES - TITLE: TUMOR CELL-INTRINSIC STING SIGNALING | $174,949 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | THE ONCOGENIC ROLES OF ALARMINS AND MONOCYTES IN TRIPLE NEGATIVE MYELOFIBROSIS - PROJECT SUMMARY MYELOFIBROSIS (MF) IS AN AGGRESSIVE CHRONIC MYELOID MALIGNANCY | $157,248 |
| 2026 | National Institutes of Health | Contract | TESTING LABORATORIES AND SERVICES 541380 | NCI - CORRECTIVE EDITING OF SPLICING FACTOR MUTANT MYELODYSPLASTIC SYNDROMES AND CHRONIC MYELOMONOCYTIC LEUKEMIA | $147,750 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | MECHANISMS OF DORMANT BREAST CANCER CELL COMMUNICATION WITH THEIR ENVIRONMENT - PROJECT SUMMARY/ABSTRACT RECURRENT METASTASES REPRESENT THE MAIN HURDLE IN CURIN | $123,182 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | INTEGRATED PROGRAM IN CANCER AND DATA SCIENCE | $122,540 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | ENGINEERING ANTIGEN-SPECIFIC TUMOR-INFILTRATING LYMPHOCYTES FOR ADOPTIVE CELL THERAPY OF HNSCC - PROJECT SUMMARY/ABSTRACT: ADOPTIVE CELL TRANSFER (ACT) WITH TU | $119,597 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DUAL E3 LIGASE FUNCTION OF TRIM25 IN MODULATING INNATE IMMUNITY - PROJECT SUMMARY/ABSTRACT INNATE IMMUNITY IS CRUCIAL FOR HUMAN HEALTH AND IS PRIMARILY REGULATE | $113,234 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | LEVERAGING NON-CANONICAL ROLE OF CDK9 TO TARGET CCNE1-AMPLIFIED HIGH-GRADE SEROUS OVARIAN CANCER - PROJECT SUMMARY/ABSTRACT GENOMIC INSTABILITY, A COMMON FEATUR | $109,107 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | TARGETING MITOCHONDRIAL STRESS RESPONSES IN MELANOMA TO ENHANCE IMMUNOTHERAPY - PROJECT SUMMARY METASTATIC MELANOMA IS A LATE-STAGE FORM OF CUTANEOUS MELANOMA T | $40,393 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | FUNCTIONAL CHARACTERIZATION OF PROSTATE CANCER RISK LOCI BY HIGH THROUGHPUT SEQUENCING | $0 |
| 2026 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | EXPLORATORY STUDY OF T CELL SKIN TRAFFICKING AND THE ROLE OF NKG2D SIGNALING; IMPLICATIONS IN VITILIGO AND MELANOMA - ABSTRACT IN THE FIELD OF IMMUNOLOGY, T CEL | $0 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DIRECT CONTROL OF THE HUMAN CMG HELICASE BY MYC AND RB - ABSTRACT THE REPLICATIVE CMG (CDC45-MCM-GINS) HELICASE PLAYS FUNCTIONAL ROLES DURING PASSAGE THROUGH TH | $0 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | KIR2DL2 IMMUNE CHECKPOINT AS MODULATOR OF T-CELL EFFECTOR FUNCTION - PROJECT SUMMARY KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTORS (KIR) ARE MAINLY EXPRESSED BY NK | $0 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | HEALTH-RELATED QUALITY OF LIFE AND PATIENT REPORTED OUTCOMES AMONG PEOPLE LIVING WITH HIV AND CANCER - PROJECT SUMMARY ADVANCES IN HIV TREATMENT HAVE IMPROVED L | -$1 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | OVERCOMING RESISTANCE TO KRAS INHIBITORS THROUGH A FRAGMENT-BASED CHEMOPROTEOMICS APPROACH - ABSTRACT A MAJOR BREAKTHROUGH IN RECENT YEARS HAS BEEN THE DEVELOPM | -$3 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | BIOPHYSICAL BASIS FOR ENZYME MEDIATED DEGLYCATION IN PROTEIN REPAIR - PROJECT SUMMARY/ABSTRACT ORGANISMS ACROSS ALL DOMAINS OF LIFE DECORATE THEIR PROTEIN MOLE | -$13 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | NEW REAGENTS FOR C-C AND C-N BOND FORMATION - PROJECT SUMMARY/ABSTRACT CHEMICAL SYNTHESIS HAS LONG BENEFITED PUBLIC HEALTH THROUGH THE DISCOVERY AND PREPARATIO | -$40 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | CARES-REACH (COLORECTAL CANCER AWARENESS, RESEARCH, EDUCATION AND SCREENING-RURAL EXPANSION, ACCESS AND CAPACITY FOR HEALTH) | -$167 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | THE ODC A ALLELE AS A DRIVER AND THERAPEUTIC TARGET OF AGGRESSIVE PROSTATE CANCER IN AFRICAN AMERICAN MEN - PROJECT SUMMARY THE RATES OF PROSTATE CANCER (PCA) | -$304 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | RANDOMIZED PLACEBO CONTROLLED TRIAL OF BUPROPION FOR CANCER RELATED FATIGUE | -$314 |
| 2026 | National Institutes of Health | Grant or other assistance | ENVIRONMENTAL HEALTH 93.113 | NOVEL ROLE OF MELANIN-CARBONYLS IN PROGRESSION OF NRAS MUTANT MELANOMA - WE DISCOVERED MELANIN-CHEMIEXCITATION (MECH) WHERE NITRIC OXIDE SYNTHASE (NOS) OXIDIZES | -$437 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | INVESTIGATING LIPID PHENOTYPE AS A METABOLIC ADAPTATION TO MICROENVIRONMENTAL STRESS - BREAST CANCERS EMERGE THROUGH A YEARS-LONG PROCESS OF SOMATIC EVOLUTION W | -$631 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ENGINEERING MODEL-BASED SYSTEMS TO MONITOR AND STEER SUBCLONAL DYNAMICS - ABSTRACT PRIMARY TUMORS AS WELL AS CANCER CELL LINES HAVE BEEN SHOWN TO EXHIBIT EXTENS | -$1,143 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | EMPLOYING FUNCTIONALIZED FRAGMENT LIBRARIES TO IDENTIFY THERAPEUTIC AGENTS FOR NEUROFIBROMATOSIS TYPE 2 - NEUROFIBROMATOSIS TYPE 2 (NF2) IS A DOMINANTLY INHERIT | -$1,816 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETING ULK3 FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER - PROJECT SUMMARY / ABSTRACT CLINICAL SIGNIFICANCE: TRIPLE NEGATIVE BREAST CANCER (TNBC) IS TH | -$2,049 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DEVELOPMENT OF BIFUNCTIONAL CDK2 INHIBITORS FOR TREATMENT OF CCNE1-DRIVEN CANCERS - PROJECT SUMMARY OVARIAN CANCER IS AMONG THE FIVE LEADING CAUSES OF CANCER DE | -$2,450 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | A STEPPED-CARE PSYCHOSOCIAL INTERVENTION FOR BRAIN TUMOR FAMILY CAREGIVERS | -$3,015 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | INVESTIGATION OF NRF2-DEPENDENT METABOLIC LIABILITIES | -$3,209 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | PARTNERING WITH A STATE FOOD BANK TO PROVIDE TOBACCO TREATMENT TO UNDERSERVED SMOKERS | -$3,519 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ANALYTICAL TOOLS FOR STUDYING THE TUMOR MICROENVIRONMENT LEVERAGING SPATIAL TRANSCRIPTOMICS - PROJECT SUMMARY/ABSTRACT UNDERSTANDING THE TUMOR MICROENVIRONMENT | -$4,750 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | RADIOMIC BIOMARKERS FOR CLINICAL DECISION SUPPORT THAT PREDICT PATIENT OUTCOMES IN SEROUS OVARIAN CARCINOMA - ABSTRACT LESS THAN A THIRD OF WOMEN DIAGNOSED WITH | -$5,114 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | THE ROLE OF HYPOXIA ON TUMOR-INFILTRATING LYMPHOCYTES (TIL) FROM RENAL CELL CARCINOMA (RCC) | -$6,410 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | IMPROVING WEIGHT LOSS OUTCOMES OF BLACK WOMEN USING A CULTURALLY RELEVANT, STRESS-MANAGEMENT ENHANCED BEHAVIORAL WEIGHT LOSS INTERVENTION | -$6,815 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | ALTERNATIVELY SPLICED CELL SURFACE PROTEINS AS DRIVERS OF LEUKEMOGENESIS AND TARGETS FOR IMMUNOTHERAPY - PROJECT SUMMARY WHILE IMPRESSIVE PROGRESS HAS BEEN MADE | -$6,883 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | TELE-RESISTANCE TRAINING DURING CHEMOTHERAPY FOR ADVANCED UPPER GASTROINTESTINAL CANCER - PROJECT SUMMARY RESISTANCE TRAINING CAN IMPROVE FITNESS, CLINICAL, AND | -$9,814 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETING A PHGDH METABOLIC VULNERABILITY IN MELANOMA - SUMMARY WHILE THE LAST 15 YEARS HAVE BROUGHT REMARKABLE CLINICAL ADVANCES IN MELANOMA THERAPY, THE CURRE | -$10,978 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | TARGETING ALTERED PHOSPHATASE-DEPENDENT SIGNALING TO OVERCOME THE INEFFICACY OF TARGETED THERAPY IN MYELOPROLIFERATIVE NEOPLASMS - PROJECT SUMMARY/ABSTRACT CLAS | -$11,627 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | CREDENTIALING A MOUSE MODEL FOR MERKEL CELL CARCINOMA | -$16,116 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | SAMBAI - ESTABLISHING A COMPREHENSIVE ASSESSMENT OF CONTRIBUTORS TO CANCER INEQUITIES ACROSS THE AFRICAN DIASPORA - SAMBAI: SOCIETAL, ANCESTRY, MOLECULAR AND BI | -$17,230 |
| 2026 | National Institutes of Health | Contract | ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES 541990 | ACQUISITION OF MOFFITT CANCER CENTER SAMPLES FOR A MULTI-ANCESTRY GENOME-WIDE ASSOCIATION STUDY OF LYMPHOID MALIGNANCIES | -$65,716 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | IMAGING ACIDOSIS AND IMMUNE THERAPY IN PDAC | -$77,860 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | RADIOMICS AND PATHOMICS TO PREDICT UPSTAGING OF DCIS - ABSTRACT DUCTAL CARCINOMAS IN SITU (DCIS) OF THE BREAST ARE A HETEROGENEOUS GROUP OF NEOPLASTIC LESIONS | -$174,225 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | DECODING THE RESISTANCE MECHANISMS TO ONCOLYTIC VIROTHERAPY IN MUSCLE-INVASIVE BLADDER CANCER | -$175,768 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | NOVEL THERAPY TO INHIBIT IPMN PROGRESSION - ABSTRACT PANCREATIC DUCTAL ADENOCARCINOMA (PDA) IS AN INCALCITRANT MALIGNANCY WITH A 5-YEAR SURVIVAL OF ONLY 10%. TH | -$1,630,227 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | USING COMBINATORIAL THERAPIES WITH DENDRITIC CELL THERAPIES TO IMPROVE SURVIVAL AND PREVENT RECURRENCE OF BREAST CANCER LEPTOMENINGEAL DISEASE (LMD) | $18,696,738 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | MOFFITT CANCER CENTER SUPPORT GRANT | $4,040,123 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | TRENDS AND OUTCOMES OF LUNG CANCER SCREENING AMONG PEOPLE WITH AND WITHOUT HIV IN THE US - IN THE UNITED STATES (US), LUNG CANCER IS THE LEADING CAUSE OF CANCER | $2,991,283 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | THE DELTA ECOLOGY OF NSCLC TREATMENT - SUMMARY – MOFFITT CSBC PROPOSAL OVERVIEW THE MOFFITT CSBC PROPOSAL IS FOCUSED ON THE ESSENTIAL AND HIGHLY DYNAMICAL INTE | $2,165,301 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | IDENTIFYING METABOLIC VULNERABILITIES IN LUNG CANCER - OVERALL PROJECT SUMMARY IDENTIFYING METABOLIC VULNERABILITIES IN LUNG CANCER LUNG CANCER IS THE MOST COMM | $2,032,950 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | IMPACT OF TERTIARY LYMPHOID STRUCTURES (TLSS) IN ONCOLYTIC VIRUS-INDUCED TUMOR ELIMINATION | $1,685,000 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | DYNAMIC: DEVELOPMENT OF A BEHAVIORAL INTERVENTION FOR YOUNG ADULTS WITH ADVANCED CANCER | $1,619,065 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | ADVANCING CLINICAL TRIALS: WORKING THROUGH OUTREACH, NAVIGATION AND DIGITAL ENABLED REFERRAL AND RECRUITMENT STRATEGIES (ACT WONDERS) - ABSTRACT LIMITED PARTICI | $1,509,955 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | AN IONIZING RADIATION ACOUSTICS IMAGING (IRAI) APPROACH FOR GUIDED FLASH RADIOTHERAPY - SUMMARY AN EMERGING RADIOTHERAPY (RT) MODALITY THAT UTILIZES ULTRA-HIGH | $1,345,854 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | PONCE SCHOOL OF MEDICINE-MOFFITT CANCER CENTER PARTNERSHIP (2/2) | $1,325,381 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | MOFFITT IMAGING BIOMARKER VALIDATION CENTER | $1,322,710 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | MODELING THE ROLE AND REGULATION OF REACTIVE STROMA IN BREAST DUCTAL CARCINOMA MICROINVASIONS - DUCTAL CARCINOMA IN SITU (DCIS) OF THE BREAST IS A HETEROGENEOUS | $1,160,532 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | CHARACTERIZING THE ROLE OF ABERRANT FGD1 SPLICING IN BRAIN AND BONE METASTASIS IN CLEAR CELL RENAL CELL CARCINOMA | $1,124,896 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | PARTNERSHIP TO ASSESS VIRAL AND IMMUNE LANDSCAPE INTERSECTIONS WITH ONCOLOGY FOR PEOPLE LIVING WITH HIV (PAVILION) - PROJECT SUMMARY – OVERALL THE PARTNERSHIP C | $1,073,611 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | IDENTIFICATION AND ASSESSMENT OF TARGETS FOR IMMUNOTHERAPY IN NF2-ASSOCIATED SCHWANNOMATOSIS | $968,875 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | HARNESSING BIG DATA TO UNDERSTAND THE CONFLUENCE OF HIV AND CANCER STIGMA IN THE US SOUTHEAST - IN THE US, DIFFERENCES IN CANCER CARE QUALITY IMPACTING PEOPLE W | $851,463 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | DEVELOPING A CANCER GALAXY COMPUTATIONAL WORKBENCH TO MEET EMERGING CANCER DATA ANALYSIS NEEDS - PROJECT SUMMARY COMPUTATIONAL ANALYSES HAVE BECOME INSTRUMENTAL | $826,483 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | USING RADIOGENOMICS TO NONINVASIVELY PREDICT THE MALIGNANT POTENTIAL OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS OF THE PANCREAS AND UNCOVER HIDDEN BIOLOGY | $820,640 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | CHARACTERIZING THE ROLE OF ABERRANT FGD1 SPLICING IN BRAIN AND BONE METASTASIS IN CLEAR CELL RENAL CELL CARCINOMA | $798,673 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | MITOCHONDRIAL STRESS PROMOTES IMMUNOSUPPRESSIVE POTENTIAL OF MYELOID SUBSETS IN TUMORS - ABSTRACT THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT (TME) ORCHESTRATE | $770,888 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | NEUROCOGNITIVE AND PATIENT-REPORTED OUTCOMES AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY: A CONTROLLED COMPARISON - PROJECT SUMMARY THERE IS WIDESPREAD EXCIT | $770,748 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | HIV GENOMIC AGING PROJECT IN ONCOLOGY (HIV-GAP) - ABSTRACT. PEOPLE WITH HIV (PWH) EXPERIENCE HIGHER CANCER MORTALITY AND INCREASED LIKELIHOOD OF CANCER RELAPSE | $763,464 |
| 2025 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | AUGMENTED REALITY AS AN ADJUNCT TO QUITLINE COUNSELING FOR SMOKING CESSATION - PROJECT SUMMARY/ABSTRACT CIGARETTE SMOKING REMAINS THE LEADING PREVENTABLE CAUSE | $759,650 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | AGING, DNA METHYLATION, AND INCIDENT CARDIOVASCULAR DISEASE IN BREAST CANCER SURVIVORS - PROJECT SUMMARY/ABSTRACT THERE ARE NEARLY FOUR MILLION BREAST CANCER SU | $734,942 |
| 2025 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | ULTRASENSITIVE DETECTION OF CIRCULATING DNA METHYLATION FOR HEAD AND NECK CANCER PROGNOSIS - PROJECT SUMMARY/ ABSTRACT HEAD AND NECK SQUAMOUS CELL CARCINOMA (HN | $716,123 |
| 2025 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | BIOMARKER APPROACH TO SCREENING FOR THE EARLY DETECTION OF HPV-RELATED OROPHARYNGEAL CANCER (BASH OPC) - ABSTRACT OROPHARYNGEAL CANCER (OPC) INCIDENCE IS SIGNIF | $715,985 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | THE MIND-BC STUDY: MIND DIET FOR BREAST CANCER COGNITION - PROJECT SUMMARY CANCER-RELATED COGNITIVE IMPAIRMENT (CRCI) IS REPORTED BY UP TO 75% OF BREAST CANCER | $713,235 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | SURVIVORSHIP IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY - PROJECT SUMMARY/ABSTRACT MULTIPLE MYELOMA IS THE SECOND M | $690,260 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | RADIOMICS AND PATHOMICS TO PREDICT UPSTAGING OF DCIS - ABSTRACT DUCTAL CARCINOMAS IN SITU (DCIS) OF THE BREAST ARE A HETEROGENEOUS GROUP OF NEOPLASTIC LESIONS | $682,707 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DEVELOPING CDK12 INHIBITORS TO OVERCOME THERAPY RESISTANCE IN HER2+ AND KRAS DRIVEN BREAST AND LUNG CANCERS - PROJECT SUMMARY ALTHOUGH THE DEVELOPMENT OF TARGET | $681,912 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | A HYBRID EFFECTIVENESS-IMPLEMENTATION TRIAL TO INTEGRATE PRECISION SKIN CANCER RISK FEEDBACK IN FEDERALLY QUALIFIED HEALTH CENTERS - ABSTRACT THE INCIDENCE OF S | $675,011 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | DISRUPTING THE PROSTATE TUMOR MICROENVIRONMENT IN AFRICAN AMERICAN MEN TO PROMOTE RESPONSE TO IMMUNO-MODULATORY THERAPY - PROJECT SUMMARY AFRICAN-AMERICAN MEN ( | $668,565 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | BODY COMPOSITION AND ADIPOSITY-ASSOCIATED THROMBOINFLAMMATION IN COLORECTAL CANCER PROGNOSIS - SUMMARY OBESITY INCREASES THE RISK OF NUMEROUS CANCERS INCLUDING | $664,642 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | IMPACT OF TARGETED THERAPY ON CANCER-RELATED COGNITIVE IMPAIRMENT - PROJECT SUMMARY/ABSTRACT CANCER-RELATED COGNITIVE IMPAIRMENT (CRCI) IS COMMON AND DISTRESSIN | $664,612 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | REMODELING THE IMMUNE LANDSCAPE IN BREAST CANCER LEPTOMENINGEAL DISEASE USING DENDRITIC CELL THERAPY IS AN EFFECTIVE TREATMENT AND PROTECTS AGAINST DISEASE RECU | $657,121 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | ENDING TOBACCO USE THROUGH INTERACTIVE TAILORED MESSAGING FOR CAMBODIAN PEOPLE LIVING WITH HIV/AIDS (ENDIT) - PROJECT SUMMARY ALTHOUGH THE PREVALENCE OF TOBACCO | $656,491 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CHARACTERIZATION AND TARGETING OF THE EPIGENETIC STATE UNDERLYING UVEAL MELANOMA LIVER METASTASIS - UVEAL MELANOMA (UM) IS A HIGHLY AGGRESSIVE AND FREQUENTLY FA | $651,147 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | ECO-EVOLUTIONARY DRIVERS OF CLONAL DYNAMICS DURING UV-INDUCED SKIN CARCINOGENESIS (PQ3) - ABSTRACT CANCERS HAVE READILY-DEFINED CHARACTERISTICS OFTEN REFERRED T | $640,021 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | SELECTIVE TARGETING OF TAF1 FUNCTION IN ACUTE MYELOID LEUKEMIA - PROJECT SUMMARY ALTHOUGH DYSREGULATED GENE TRANSCRIPTION IS A MAJOR CONTRIBUTING FACTOR IN CANC | $635,624 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | ORAL HPV RESEARCH AMONG LATIN AMERICANS LIVING WITH HIV (ORAL - H? STUDY) - ABSTRACT OROPHARYNGEAL CANCER (OPC) IS PREDOMINANTLY CAUSED BY HPV 16 AND OTHER ONCO | $625,843 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | AN INTEGRATED MATHEMATICAL MODELING APPROACH TO DEFINE HOW THE AGING BONE ECOSYSTEM DRIVES MULTIPLE MYELOMA EVOLUTION AND TREATMENT RESPONSE - PROJECT SUMMARY S | $620,521 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | A REDOX-SENSITIVE SWITCH IN THE MACROPHAGE NUCLEUS REGULATES ACUTE PHASE INFLAMMATORY INJURY - SUMMARY THIS APPLICATION IS BASED ON THE DISCOVERY THAT REACTIVE | $613,814 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | EPIGENETIC AND METABOLIC BOTTLENECKS OF TUMORIGENESIS - RECURRENT METASTASIS IS THE LEADING CAUSE OF BREAST CANCER MORTALITY. DORMANCY IS A CRITICAL, BUT POORLY | $598,888 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | METHYLOMIC BASIS OF SURVIVAL DISPARITIES AMONG BLACK AND WHITE WOMEN WITH HIGH-GRADE SEROUS OVARIAN CANCER - ABSTRACT EPITHELIAL OVARIAN CANCER IS THE DEADLIEST | $596,383 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | RELEASE OF INTERLEUKIN-1A AS A MEDIATOR OF IMMUNE EVASION IN CANCER - PROJECT SUMMARY CELL DEATH IS THE PRIMARY GOAL OF MOST CANCER THERAPIES, BUT HOW DIFFERENT | $568,538 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CHARACTERIZING CYTOTOXIC THERAPY INDUCED SHIFTS IN THE COST-TO-BENEFIT RATIO OF HIGH PLOIDY - SUMMARY TRADITIONAL PHASE I DOSE-FINDING STRATEGIES MONITOR DRUG R | $562,055 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | MYC-ALARMIN AXIS AS A NOVEL THERAPEUTIC VULNERABILITY IN MYELOFIBROSIS - PROJECT SUMMARY MYELOFIBROSIS (MF) IS A HEMATOLOGIC MALIGNANCY THAT IS CHARACTERIZED BY | $553,041 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | STRUCTURE-FUNCTION STUDIES OF LAG3 INTERACTIONS WITH ANTIBODIES AND CELLULAR LIGANDS - PROJECT ABSTRACT IN THIS PROPOSAL, WE WILL DETERMINE HOW ANTIBODIES AND C | $549,962 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | PROGRAM CONTROL OF CD8+ T CELL RESPONSE TO TUMORS AND TUMOR MEMORY - ABSTRACT CD8+ TUMOR INFILTRATING LYMPHOCYTES (TILS) ARE NOT ONLY CRITICAL FOR THE ANTI-TUMO | $549,460 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | EFFICACY OF A MINDFULNESS-BASED STRESS MANAGEMENT PROGRAM FOR ALLOGENEIC HCT CAREGIVERS - PROJECT SUMMARY/ABSTRACT CARING FOR AN ALLOGENEIC HEMATOPOIETIC STEM C | $543,261 |
| 2025 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | TARGETING MALIGNANT REPROGRAMMING OF GLIOBLASTOMA STEM CELLS THROUGH DUAL INHIBITION OF S6K1 AND BIRC3 - GLIOBLASTOMA (GBM) IS HIGHLY RESISTANT AND UNIFORMLY FA | $541,074 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | ROLE OF ULK3 IN SENSITIVE AND REFRACTORY MULTIPLE MYELOMA - SUMMARY MULTIPLE MYELOMA (MM) IS AN INCURABLE AND FATAL DISEASE. REAGENTS SUCH AS THE PROTEASOME INH | $534,381 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CHROMOSOME 1Q CERNAS IN MELANOMA PROGRESSION AND METASTASIS - PROJECT SUMMARY METASTASIS IS THE MAIN CAUSE OF DEATHS RELATED TO MALIGNANT MELANOMA. STUDIES OVER | $530,554 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | THE IMPACT OF INFLAMMATION ON HSPC COMPOSITION AND DISEASE PROGRESSION IN CHRONIC MYELOMONOCYTIC LEUKEMIA - PROJECT SUMMARY: CHRONIC MYELOMONOCYTIC LEUKEMIA (CM | $522,013 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | IDENTIFYING CELL SURFACE TARGETS FOR INNOVATIVE IMMUNOTHERAPY OF MULTIPLE MYELOMA - PROJECT SUMMARY MULTIPLE MYELOMA (MM) IS AN INCURABLE MALIGNANCY OF MATURE P | $507,197 |
| 2025 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | ROLE OF CRTC1-MAML2 IN SALIVARY MUCOEPIDERMOID CARCINOMA PATHOBIOLOGY - SUMMARY MUCOEPIDERMOID CARCINOMAS (MEC) ARE THE MOST COMMON TYPE OF MALIGNANT SALIVARY G | $497,736 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DEFINING AND TARGETING EPIGENETIC PLASTICITY-DRIVEN DRUG RESISTANCE AND IMMUNE ESCAPE IN MELANOMA - PROJECT SUMMARY MELANOMA IS A HETEROGENEOUS TUMOR, WITH A HI | $485,968 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | INTERROGATING THE RELATIONSHIP BETWEEN TRANSLATIONAL DYNAMICS AND NON-CANONICAL ANTIGEN PRESENTATION IN LUNG CANCER - ABSTRACT ANTIGEN PRESENTATION IS A FUNDAME | $485,494 |
| 2025 | National Institutes of Health | Grant or other assistance | ENVIRONMENTAL HEALTH 93.113 | SUPPRESSION OF PROGESTERONE RECEPTOR SIGNALING BY HEAVY METALS PROMOTES TAMOXIFEN RESISTANCE AND METASTASIS OR ER+ BREAST CANCER - SUMMARY THE CENTRAL CONCEPT I | $480,443 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | DEVELOPING AND CREDENTIALING PATIENT-DERIVED XENOGRAFT MODELS TO ADVANCE THERAPEUTIC APPROACHES FOR CHRONIC MYELOMONOCYTIC LEUKEMIA | $477,698 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | MATHEMATICAL MODEL-GUIDED ADOPTIVE IMMUNOTHERAPY IN BLADDER CANCER - SUMMARY BLADDER CANCER IS THE FOURTH MOST COMMON CANCER IN MEN AND A LEADING CAUSE OF CANCE | $476,037 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | ILLUMINATING NOTCH RECEPTOR-LIGAND SELECTIVITY THROUGH STRUCTURE-GUIDED PROTEIN ENGINEERING | $463,375 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | RBFOX2 DEREGULATION PROMOTES PANCREATIC CANCER PROGRESSION THROUGH ALTERNATIVE SPLICING - SUMMARY SPLICING IS A CRITICAL BIOLOGICAL PROCESS IN CANCER INITIATION | $461,101 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DEFINING IMPACT OF IN SITU ACTIVATION OF CD40 AND TYPE 1 INTERFERON SIGNALING ON THETME AND SYSTEMIC T CELL IMMUNITY IN MURINE MODELS AND CANCER PATIENTS - PROJ | $460,204 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | GENETIC RISK OF PROSTATE CANCER IN SELF-IDENTIFIED BLACK VETERANS | $459,360 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | ANTI-TUMOR POTENTIAL OF TEMPERATURE-SENSITIVE P53 MUTANTS - THE P53 TUMOR SUPPRESSOR IS FREQUENTLY INACTIVATED BY MUTATIONS IN CANCER. MOST P53 POINT MUTATIONS | $444,591 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | EXPLORING ANTI-SENSE RNAS IN MELANOCYTE TRANSFORMATION AND MELANOMA FORMATION - SUMMARY IN THE LAST DECADE, NONCODING RNAS (NCRNAS) HAVE EMERGED AS KEY REGULATO | $433,256 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | THE INFLUENCE OF EXTREME WEATHER EVENTS ON EMERGENCY DEPARTMENT UTILIZATION AMONG CANCER PATIENTS IN FLORIDA - EXTREME WEATHER IS BECOMING MORE FREQUENT AND SEV | $423,462 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DISSECTING ENHANCER FUNCTION THROUGH INTEGRATIVE GENOMICS - PROJECT SUMMARY ENHANCERS ARE NON-CODING REGULATORY ELEMENTS THAT DIRECTLY INVOLVED IN MODULATING CE | $421,250 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | BIOPHYSICAL BASIS FOR ENZYME MEDIATED DEGLYCATION IN PROTEIN REPAIR - PROJECT SUMMARY/ABSTRACT ORGANISMS ACROSS ALL DOMAINS OF LIFE DECORATE THEIR PROTEIN MOLE | $411,750 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | NEW REAGENTS FOR C-C AND C-N BOND FORMATION - PROJECT SUMMARY/ABSTRACT CHEMICAL SYNTHESIS HAS LONG BENEFITED PUBLIC HEALTH THROUGH THE DISCOVERY AND PREPARATIO | $411,750 |
| 2025 | National Institutes of Health | Grant or other assistance | ENVIRONMENTAL HEALTH 93.113 | H3 HISTONE OXIDATION IS A NEW POSTTRANSLATIONAL MODIFICATION LINKING HEAVY METAL-INDUCED METABOLIC CHANGES AND ONCEGENIC EPIGENETIC REPROGRAMMING - SUMMARY TRAN | $387,660 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | BILE ACIDS RESTRICT FUNCTIONAL REPROGRAMMING OF MYELOID-DERIVED SUPPRESSOR CELLS IN TUMOR BEDS - ABSTRACT THE EXPANSION OF MYELOID-DERIVED SUPPRESSOR CELLS (MDS | $376,751 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CHARACTERIZING ONCOGENIC FUNCTION OF ITCH IN MELANOMA - ABSTRACT THE ITCH UBIQUITIN E3 LIGASE HAS BEEN WELL CHARACTERIZED AS A KEY MOLECULE IN IMMUNE CELLS. THE | $357,913 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | MECHANISMS OF P53 ACTIVATION DURING STRESS RESPONSE | $338,330 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | QUANTIFYING SPATIAL PROPERTIES OF IMMUNOSUPPRESSIVE MACROPHAGES IN PAPILLARY RENAL CELL CARCINOMA | $328,574 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | DETERMINING THE STRUCTURAL-AND FUNCTIONAL-LEVEL EFFECTS OF DIET-SPECIFIC INTERVENTIONS ON THE GUT-MICROBIOTA OF A DIVERSE SAMPLE OF SOUTHERN UNITED STATES ADULT | $319,019 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | LIBRE DEL CIGARRILLO: DEVELOPMENT OF AN MHEALTH SMOKING CESSATION APP TO EXTEND REACH OF A VALIDATED SMOKING CESSATION INTERVENTION FOR SPANISH-SPEAKING SMOKER | $316,873 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | ADAPTATION AND PRELIMINARY EVALUATION OF ENERGIZE-MBC: COGNITIVE BEHAVIORAL THERAPY FOR FATIGUE AMONG WOMEN WITH METASTATIC BREAST CANCER - PROJECT SUMMARY/ABST | $308,399 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DEVELOPING CHEMICAL PROBES FOR ONCOGENIC SIGNALING PATHWAYS | $293,933 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | GHANA INTEGRATIVE APPROACH TO CANCER RESEARCH TRAINING: THE GRACE PROGRAM - PROJECT SUMMARY/ABSTRACT CANCER INCIDENCE IS SIGNIFICANTLY INCREASING IN MANY SUB-SA | $272,490 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TARGETING ANTIOXIDANT VULNERABILITIES IN KEAP1/NRF2 MUTANT NSCLC - THE TRANSCRIPTION FACTOR NRF2 IS A CENTRAL REGULATOR OF CELLULAR REDOX BALANCE. MUTATIONS IN | $248,578 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | DEVELOPMENT OF ADVERSE EVENT (AE) DERIVED BIOMARKERS FOR PREDICTING CLINICAL OUTCOMES IN LUNG CANCER - PROJECT SUMMARY/ABSTRACT ADVERSE EVENT (AE) IS A CRITICAL | $236,321 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | BEHAVIORAL ONCOLOGY EDUCATION & CAREER DEVELOPMENT | $218,939 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CORE CLINICAL CENTERS FOR THE BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK (UG1) | $214,179 |
State business registration
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. FL, Domestic nonprofit corporation (DOMNP), Active, formed 1994-03-30
The same business name in the same state, from the state’s official registry data.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Payment recipient | H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL INC | FL | Open Payments (drug and device company payments) | name and state |
| Payment recipient | H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE HOSPITAL | FL | Open Payments (drug and device company payments) | name and state |
| Payment recipient | H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE HOSPITAL INC | FL | Open Payments (drug and device company payments) | name and state |
Matched by name (and state) or EIN only; a shared name is not proof of the same person or organization.
Comments